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Using E. coli as an experimental system to study the behavior of prion-like proteins. 
 
ABSTRACT 
 
Prions are infectious, self-propagating protein aggregates that have been uncovered in 
evolutionary divergent members of the eukaryotic domain of life. It is not known whether 
prokaryotic organisms contain proteins that exhibit prion-like behavior. However, studies 
have shown that the E. coli cytoplasm can support conversion of the well-characterized 
Saccharomyces cerevisiae yeast prion protein Sup35 into the prion form and that this 
conversion, like in the yeast system, is dependent on the presence of amyloid aggregates 
of another yeast prion protein, a so-called PIN factor. It is interesting that the bacterial 
system recapitulates the in vivo requirements for Sup35 prion formation in the native 
yeast system despite the fact that bacteria diverged from eukaryotes ~2.2 billion years 
ago. In yeast, once formed, the Sup35 prion is stably propagated and this process is 
independent of the PIN factor. Using the same yeast prion protein, Sup35, in CHAPTER 
2 we show that prion aggregates can be maintained for up to 90 generations in the 
bacterial cytoplasm and that these aggregates are still infectious when transformed into 
yeast.  
Studies in yeast have implicated cellular chaperones in the de novo formation of prion 
aggregates, but the effect of the bacterial chaperone system on the formation of prion-like 
aggregates remains to be investigated. In CHAPTER 3, we use the non-prion, amyloid 
forming bacterial protein CsgB as a model protein in designing an assay to identify 
cellular factors that interfere with amyloid formation. Using the cytoplasmic amyloid 
aggregation of this protein as a surrogate for the initial formation of prion-like 
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aggregates, we identify three open reading frames in E. coli that, when overexpressed, 
potentially inhibit cytoplasmic amyloid aggregation. The work presented in this 
dissertation demonstrates that E. coli can be used as an experimental system to study the 
behavior of known and putative prion proteins. This system may be especially useful in 
studying the interaction of prions with cellular chaperones. Our findings increase our 
interest in the search for bacterial proteins that may be able to function as prions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   v	  
TABLE OF CONTENTS 
CHAPTER 1: Introduction ...............................................................................................1 
THE PRION PHENOMENON AND MAMMALIAN PRIONS ........................................2 
PRIONS IN YEAST ............................................................................................................4 
Role of the chaperone systems in yeast prion propagation ............................................9 
PRION STRAIN AND SPECIES BARRIERS .................................................................11 
BACTERIAL PRIONS ......................................................................................................14 
Yeast prions can access the infectious conformation in E. coli ...................................15 
FOCUS OF THE DISSERTATION ..................................................................................16 
REFERENCES ..................................................................................................................18 
CHAPTER 2: Propagation of a yeast prion protein in E. coli .....................................26 
ATTRIBUTIONS ..............................................................................................................27 
ABSTRACT .......................................................................................................................28 
INTRODUCTION .............................................................................................................29 
RESULTS ..........................................................................................................................32 
The infectious Sup35 prion aggregates can be maintained in the bacterial cytoplasm 
for 30 generations following the shut off of PIN synthesis .........................................32 
 
Heat shock does not have a negative impact on the heritability of the infectious NM 
prion aggregates in the bacterial cytoplasm .................................................................38 
 
The infectious NM prion aggregates are maintained in the bacterial cytoplasm for up 
to 90 generations following PIN excision ....................................................................46 
 
DISCUSSION ....................................................................................................................57 
MATERIALS AND METHODS .......................................................................................60 
REFERENCES ..................................................................................................................63 
SUPPLEMENT TO CHAPTER 2: Study of Sup35NM-YFP fusion protein levels ..65 
	   vi	  
ATTRIBUTIONS ..............................................................................................................66 
RESULTS AND DISCUSSION ........................................................................................67 
The arabinose inducible system results in fluctuating levels of full-length NM protein 
from colony to colony as well as in the same clone over successive rounds of 
restreaking ....................................................................................................................67 
 
CHAPTER 3: Identifying cellular factors that influence amyloid formation in  
E. coli .................................................................................................................................76 
 
ATTRIBUTIONS ..............................................................................................................77 
ABSTRACT .......................................................................................................................78 
INTRODUCTION .............................................................................................................79 
RESULTS ..........................................................................................................................83 
Selection system used to identify bacterial factors that influence amyloid formation in 
E. coli and identification of candidate ORFs ...............................................................83 
 
Initial validation of candidate ORFs ............................................................................90 
DISCUSSION ....................................................................................................................93 
MATERIALS AND METHODS .....................................................................................100 
REFERENCES ................................................................................................................102 
CHAPTER 4: Discussion ...............................................................................................105 
SUMMARY .....................................................................................................................106 
FUTURE DIRECTIONS .................................................................................................109 
Experiments to better understand heritability of yeast prions in bacteria ..................109 
Further characterization of the three ORFs implicated in relieving the toxicity of the 
CI-CsgB fusion protein ..............................................................................................117 
 
REFERENCES ................................................................................................................121 
 
 
	   vii	  
LIST OF FIGURES 
CHAPTER 2: Propagation of a yeast prion protein in E. coli 
 
Figure 2.1:   Experimental design for studying prion heritability in E. coli following 
shut off of New1 synthesis .........................................................................34 
 
Figure 2.2:   NM aggregates can be maintained for 30 generations in E. coli in the 
absence of New1 ........................................................................................35 
 
Figure 2.3:   Experimental design for studying prion heritability in E. coli under 
conditions that permit the removal of the new1 gene  ...............................41 
 
Figure 2.4:   Heat shock does not negatively affect the maintenance of NM aggregates 
in E. coli .....................................................................................................42 
 
Figure 2.5:   Confirming new1 removal from the chromosome .....................................48 
 
Figure 2.6:   Results of heritability experiments following new1 removal from the 
chromosome ...............................................................................................49 
 
Figure 2.7:   Experimental design for studying prion heritability in E. coli following 
additional rounds of restreaking after new1 removal .................................51 
 
Figure 2.8:   Results of heritability experiments after 3 additional rounds of restreaking 
following new1 removal ............................................................................52 
 
SUPPLEMENT TO CHAPTER 2: Study of Sup35NM-YFP fusion protein levels 
 
Figure 2.9:   Arabinose induction results in varying NM-YFP full-length protein levels 
from colony to colony and in the same clone over time ............................68 
 
Figure 2.10:   Dilution into fresh medium leads to a drastic reduction in NM-YFP 
protein levels but does not affect the New1-CFP protein levels ................74 
 
CHAPTER 3: Identifying cellular factors that influence amyloid formation in E. coli 
 
Figure 3.1:   Experimental design for identifying ORFs that affect amyloid formation E. 
coli ..............................................................................................................84 
 
Figure 3.2:   λCI-CsgB causes cell toxicity starting at an IPTG concentration of 125µM  
 ....................................................................................................................86 
 
Figure 3.3:   Reconfirmation of toxicity relief by ORFs identified in the selection .......88 
 
	   viii	  
Figure 3.4:   The ORFs identified in the selection do not downregulate λCI -CsgB 
protein levels ..............................................................................................92 
 
Figure 3.5:   Experimental design to determine whether the selected ORFs decrease 
formation of CsgB amyloids ......................................................................96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   ix	  
LIST OF TABLES 
CHAPTER 2: Propagation of a yeast prion protein in E. coli 
 
Table 2.1:   NM aggregates maintained in E. coli in the absence of New1 for 30 
generations are infectious when transformed into yeast cells ....................39 
 
Table 2.2:   Heat shock does not negatively affect the infectivity of NM aggregates in 
E. coli .........................................................................................................45 
 
Table 2.3:   Infectivity of NM aggregates maintained in E. coli for 3 additional rounds 
of restreaking following new1 removal from the chromosome  ................55 
 
Table 2.4:   Plasmids and strains used for this study ....................................................56 
 
CHAPTER 3: Identifying cellular factors that influence amyloid formation in E. coli 
 
Table 3.1:   A list of the clones obtained in the selection using relief of toxicity as a 
readout of decreased aggregating ability ...................................................87 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   x	  
ACKNOWLEDGEMENTS 
The work presented in this thesis would not have been possible without the help and 
support of many people. First and foremost, my advisor, Dr. Ann Hochschild, has been 
an extraordinary mentor to me. She has provided me with never-ending support, advice 
and encouragement throughout my time in her lab. She has tirelessly helped me navigate 
through all the aspects of graduate school, be it experiment design, data interpretation, 
scientific writing or career planning. Ann has been a wonderful model not only of what 
an advisor should be, but most importantly, what a human being should be. I have found 
it very easy to talk to her about most aspects of my life and this is a testament to her 
genuine interest and care in the overall well-being and happiness of the people around 
her. I am deeply grateful to have had the chance to work in her lab. I also wish to thank a 
former graduate student in the lab, Dr. Sean J Garrity. Sean has been someone I have 
constantly turned to for help with my project and someone who has always been willing 
to take the time to assist me with anything I needed, without ever appearing annoyed or 
bothered. He is simply one of the brightest and most pleasant people I have ever had the 
pleasure to work with. 
I especially wish to thank my Dissertation Advisory Committee- Dr. Andrew Murray, 
Dr. Rachelle Gaudet, Dr. Simon Dove and Dr. Rich Losick- for their helpful comments 
with my project and for our productive discussions. I would not have made it to this point 
without their directions and guidance. 
Deserving thanks beyond what I could ever be able to express, is my mother, Jola 
Kukli. Her unconditional love and support have guided me through every single moment 
of my life. Her dedication to the education of her children, and her patience with them are 
	   xi	  
truly unique. It is an understatement to say that everything that is good in me today is that 
way because of her. My 15-year-old sister, Liana, is a constant source of joy in my life. 
My conversations with her brighten up my worst day and I am constantly amazed at her 
emotional and intellectual maturity. I also want to thank the rest of my family, my father-
Agron, my grandmother-Kadrije, my two brothers-Denis and Klevis for supporting me in 
everything I do. 
Perhaps one of the things I am most grateful to graduate school for, is that it has 
introduced me to the people who have become my US family. My best friends, Monica, 
Hilary, Polina and Florian have been there for me, every step of the way, lending an ear, 
a shoulder to cry on, cheering me on and looking ridiculous dancing to Italian pop music 
with me until we would have to stop for breath. Their friendship is one of the things I 
value most in my life. My lab mate and my boyfriend, Nik, has been such a wonderful 
influence in my life. His support, both personal and scientific, has meant so much to me. 
His words and embraces have the incredible ability to make me relax when I am the most 
stressed. His dedication to preparing my breakfast and whole milk latte for me every 
single morning, without fail, makes me look forward to starting each day, no matter how 
hectic. But above all, I am most thankful to him for making me happier than I ever 
thought I could be. 
 
 
 
 
	   1	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1 
 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   2	  
THE PRION PHENOMENON AND MAMMALIAN PRIONS 
 
Prions are infectious, self-propagating protein aggregates that have been uncovered in 
mammals as well as yeast and other fungi. In mammals, they cause a group of fatal 
neurodegenerative diseases referred to as the transmissible spongiform encephalopathies 
(TSEs) [1].  Examples of TSEs that affect humans are Creutzfeld-Jacob disease (CDJ), 
Gerstmann-Straussler-Scheinker Syndrome (GSS), fatal familial insomnia (FFI) and 
Kuru. Well known TSEs that affect other mammals include sheep scrapie and bovine 
spongiform encephalopathy (BSE), which has been experimentally linked to the novel 
human prion disease variant vCDJ [2, 3].  
Initial studies on the agent responsible for the TSEs revealed that it had unusual 
characteristics (resistance to high temperatures, chemicals and UV radiation) [3] that did 
not seem consistent with conventional pathogens such as bacteria or viruses. In 1967, 
Alper et al suggested that the infectious agent of scrapie lacked any nucleic acid [4] and 
in that same year Griffith formulated the “protein only hypothesis” and proposed three 
mechanisms to explain the replication mechanism of this infectious agent [5]. Several 
years later, in 1982 Stanley Prusiner coined the term prion for proteinaceous infectious 
particle to describe the infectious agent of scrapie in sheep [6]. 
Since then, work in the field has identified the altered, aggregated form of an 
endogenous protein called PrPC as the causative agent of TSEs [7, 8]. PrPC is a cell 
surface glycosyl phosphatidyl inositol (GPI) linked glycoprotein and it has been 
identified in all mammals examined to date [9, 10]. Although several functions, including 
neuroprotective signaling, neurite growth and cell growth and viability in response to 
oxidative stress, have been proposed for PrPC, its physiological role still remains 
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unknown [11-16]. PrPC has an inherent ability to convert to a protease resistant, 
aggregated form called PrP-scrapie (PrPsc) that is the basis for prion formation. A 
defining characteristic of these aggregates is that they induce the conversion of normally 
folded protein to the prion form. PrPsc aggregates are infectious and they can spread not 
only in infected individuals but also between individuals. Prion disease can be 
transmitted in laboratory models via intracerebral, intravenous, intraperitoneal and 
intraocular inoculation of infectious material, but in the field they can also be induced via 
oral challenge [9]. 
Infectious PrP aggregates, as well as fungal prion aggregates (see below), are 
composed of highly structured beta sheet-rich fibrils, known as amyloid fibrils.  Within 
such fibrils the beta-sheets are made up of beta-strands that are oriented perpendicular to 
the fibril axis, arranged in a “cross-beta structure” [17, 18]. In general, amyloid 
aggregates are unusually rugged, exhibiting resistance to denaturation in SDS and 
protease digestion. Amyloid aggregates also characteristically bind the dyes Congo Red 
and Thioflavin T.  
Prion diseases represent just a small subset of a much larger group of protein-
misfolding diseases, known as the amyloidoses. There are more than 30 human amyloid 
diseases (e.g. Alzheimer’s, Huntington’s and Parkinson’s disease) and they are 
characterized by the deposition of the fibrous aggregates in different tissues. Although 
the amyloid forming protein in each of these diseases is different, protein misfolding 
leads in each case to the characteristic cross-beta structure. Contrary to prion diseases, 
amyloid diseases are typically considered not to be infectious. Interestingly, recent work 
has raised the possibility that in these diseases the protein misfolding process might 
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propagate itself in a manner that is mechanistically related to what occurs in prion disease 
[19-21]. In addition, recent evidence indicated that PrPC might play a direct role in the 
pathogenesis of Alzheimer’s disease in particular [22, 23]. Thus, a better understanding 
of prion diseases and their mechanism of transmission and propagation may shed light 
into the mechanistic underpinnings of many other devastating and common 
neurodegenerative disorders. 
 
PRIONS IN YEAST 
The discovery of prion forming proteins in fungi and especially yeast cells has led to 
great advances in the understanding of prion biology. The first yeast prion to be 
uncovered was the so-called [URE3] prion [24], the prion isoform of the Ure2 protein 
(Ure2p). (Note that the prion state is designated with capital letters to indicate dominance 
and brackets to indicate cytoplasmic inheritance.) Ure2p is a regulator of nitrogen 
catabolism that inhibits the expression of genes required for the uptake of poor nitrogen 
sources in the presence of a good nitrogen source. However, yeast cells carrying the 
[URE3] prion lack active Ure2p and as a result take up poor nitrogen sources (such as 
ureidosuccinate/USA) even though they are grown in the presence of a good nitrogen 
source [24]. 
The discovery of the [URE3] prion traces back to 1971, when Francois Lacroute, 
working on uracil biosynthesis identified mutant yeast cells that could grow on 
ureidosuccinate despite the presence of ammonium [25]. One of these mutants, named 
[URE3] was a non-chromosomal mutant and, unlike the other two mutants, displayed a 
dominant, non-Mendelian fashion of inheritance. Moreover, later studies showed that 
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chromosomal mutants in ure2 could not propagate the [URE3] genetic element [26]. 
Working from these initial observations, in 1994 Reed Wickner presented genetic 
evidence to suggest that [URE3] was, in fact, a prion [24]. Specifically, the presence of 
[URE3] resulted in the same loss-of-function phenotype as observed in the case of Ure2p 
chromosomal mutants [24, 27]. Indeed, in the prion state, the prion protein is sequestered 
in the prion aggregates and as a result, the prion phenotype typically resembles the loss-
of-function phenotype (note that this not true in the case of mammalian prions as deletion 
of the gene encoding PrP produces no clear phenotype but PrPsc is lethal). Additionally, 
cells cured of [URE3] by treatment with guanidine (see below for a discussion on curing 
of the prion state), could revert back to the [URE3] state at a frequency similar to the 
original appearance of [URE3]. Moreover, overproduction of Ure2p, enhanced the 
frequency of [URE3] appearance by 100-200 fold [27].  Based on these observations, 
Reed Wicker proposed that [URE3] was a prion of Ure2p. Furthermore, Wickner’s 
observation with [URE3] provided a set of genetic criteria that was used subsequently to 
identify additional prions in yeast. 
It is important to note that, none of the genetic criteria for [URE3] or yeast prions in 
general apply to mammalian prions [27]. As mentioned above, deletion of the gene 
encoding PrP does not produce a phenotype similar to the phenotype produced when the 
PrP protein is in the prion conformation. Also, there are no known cures for TSE and 
therefore, it is not possible to test the frequency of spontaneous TSE appearance 
following curing of the prion state. Additionally, overexpression of PrP kills mice, but it 
does not lead to the generation of the prion state (the tissues of these mice are not 
infectious) [27]. Finally, yeast prions cause phenotypic changes in yeast cells that are 
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stably propagated from generation to generation, unlike the prion form of PrP, which 
causes cell death as it spreads. 
Among fungal prions, the Sup35 prion has been the subject of particularly intensive 
study. Sup35, which is an essential translation termination factor, has a modular structure, 
with the N terminal region (N) containing the essential prion forming domain 
(comprising a Q- and N-rich fragment and five copies of an imperfect oligopeptide 
repeat), and the highly charged middle region (M) enhancing the solubility of Sup35 in 
the nonprion form and stabilizing the prion form, which is designated [PSI+][28]. The C-
terminal domain of Sup35 provides the translation termination activity of Sup35 but is 
not required for its prion behavior. Studies have shown that, when transferred to 
heterologous proteins, the N and M regions of Sup35, designated NM, confer prion 
behavior on the resulting fusion protein [29]. 
In [psi-] cells (i.e. cells lacking the Sup35 prion), Sup35 is soluble and able to 
properly terminate translation. In [PSI+] cells, however, Sup35 is largely sequestered in 
prion aggregates, resulting in impaired translation termination and the suppression of 
nonsense mutations. The [PSI+] state can easily be detected by suppression of nonsense-
codon mutations in auxotrophic markers [30]. The [PSI+] state, like prion states in 
general, is inherited in a dominant, non-Mendelian fashion and is stably propagated over 
multiple generations. 
The spontaneous conversion of the Sup35 from the soluble form to the prion form is a 
rare event with a frequency of 10-6 per total colonies analyzed, and is dependent on the 
presence of yet another yeast prion referred to as PIN, for [PSI+] inducibility, factor [31].  
PIN is required for the de novo appearance of [PSI+], but not for its propagation [32, 33]. 
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The prion-forming properties of Ure2p and Sup35 depend on a glutamine and 
asparagine rich (Q/N-rich) region within the N terminal domain of each protein. Genome 
wide searches for Q/N-rich domains have led to the identification of other yeast proteins 
with prion domains, including New1p and Rnq1p. (Note that the Q/N-rich domain of 
New1 is also referred to as the NYN repeat region.) Although no phenotypic changes 
have yet been associated with the inactivation of these two proteins, in its prion form, 
each one functions as a PIN factor, rendering the cells [PIN+] [32, 34, 35]  
As already mentioned, an important difference between mammalian and yeast prions 
is that, unlike mammalian prions, yeast and fungal prions do not typically result in cell 
death. In fact, recent evidence suggests that prion formation may be beneficial under 
particular circumstances [36-38] but see [39, 40], for the opposing view. A growing body 
of work suggests that prions do not represent disease states in yeast, but instead that 
conversion to the prion state might serve as mechanism to reversibly modulate the 
phenotype in fluctuating environments. Researchers have argued that conversion to the 
prion state could allow yeast cells to test normally suppressed phenotypes and could 
promote adaptive evolvability [36]. Consistent with this hypothesis, studies have shown 
that stress states such as oxidative stress or high salt concentrations can increase the 
conversion frequency of Sup35 to the prion state [41]. The known repertoire of prions in 
the fungal kingdom is rapidly expanding, providing further support for the idea that 
heritable protein aggregates have functional and beneficial roles in the cell. Indeed, yeast 
prion proteins have been shown to play many different cellular roles including but not 
limited to, chromatin remodeling [42, 43], transcriptional regulation [42, 44] and cell 
cycle dynamics [42, 45]. 
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For example, [PSI+] strains of Saccharomyces cerevisiae were found to exhibit 
enhanced tolerance to heat and chemical stress as compared to [psi-] yeast strains [37, 46, 
47].  However, if prions are beneficial, then they should be found in wild strains as well 
as laboratory strains. This was the motivation for the study by Linquist and colleagues, 
which looked beyond Sup35 to ask about prions more generally. In this study, the authors 
tested wild strain of Saccharomyces for presence of prions and found them in a 
considerable fraction of the strains tested [38]. The group also found that these prion 
states conferred phenotypes that were beneficial under some stressful conditions tested.  
Other groups have also identified yeast prions that result in phenotypic changes that 
prove advantageous under certain environmental stress conditions. For example, in its 
prion state, the recently identified yeast prion protein Mod5 confers cellular resistance 
against antifungal agents and furthermore, selective pressure by antifungal drugs 
increases the de novo appearance of the Mod5 prion state (designated [MOD+]) in yeast 
[48]. Interestingly, unlike other yeast prion proteins, Mod5 does not contain a Q/N-rich 
region [44, 48].   
Aside from the prions described in yeast, another prion was shown to control 
heterokaryon incompatibility in the evolutionary divergent filamentous fungus, 
Podospora anserine [17]. Filamentous fungi have developed self/non-self recognition 
systems limiting the cellular fusion of different colonies to genetically identical partners. 
This process is dependent on the het-loci and P. anserine has nine such loci, one of 
which, het-s, involves a prion protein [49]. The het-s locus has two allelic variants named 
het-s and het-S. Strains expressing the Het-s protein in the soluble form are compatible 
with strain expressing the Het-S protein and these strains can engage in cellular fusion. 
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However, the Het-s protein can spontaneously convert to the prion conformation (termed 
[Het-s], making the strains harboring the prion incompatible with the strains harboring 
the Het-S protein [50]. A fusion event between these two strains results in cell death 
(heterokaryon incompatibility).  A cell with the [Het-s] phenotype can however fuse to a 
cell expressing the Het-s protein and, when this happens, the [Het-s] amyloid spreads to 
the other cell and converts it to the [Het-s] compatibility phenotype [49]. Due to its 
involvement in heterokaryon incompatibility, the prion form of Het-s represents another 
example of prions having functional roles within the cell.  
 
Role of the chaperone systems in yeast prion propagation 
Propagation of prions depends on their ability to grow the aggregate by recruiting 
soluble protein of the same type and converting it to the amyloid form. However, the 
amyloid fibers need also to be fragmented in order to create prion seeds that function as 
new catalytic ends to recruit additional soluble protein. This process of propagation and 
fiber fragmentation in mammals is still not understood. 
Studies in yeast however, have implicated cellular chaperones and the heat-shock 
protein Hsp104, in particular, in the propagation of yeast prions. Hsp104 is a member of 
the Hsp100/ClpB family of the hexameric AAA+ ATPases. This family of proteins 
includes bacterial, fungal and plant ATPases [51-54]. The Hsp104/ClpB chaperones work 
together with the Hsp70/40 chaperone system to break down large protein aggregates or 
remodel non-natively folded polypeptides [55-57]. This process involves the extraction of 
single polypeptide chains from the aggregates and threading them through the central 
channel of the Hsp100/ClpB hexamer [58, 59]. 
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Hsp104 was initially identified as an important factor for the development of 
thermotolerance in yeast [60, 61].  Studies have shown that, under stress conditions, yeast 
strains missing or containing a mutated Hsp104 have a reduced survival rate as compared 
to wild-type strains [62, 63]. Under normal growth conditions, Hsp104 plays a critical 
role in prion propagation. Thus, cells lacking Hsp104 are unable to propagate any of the 
known yeast prions, including [PSI+]. Moreover, the inhibition of Hsp104 activity, which 
can be accomplished by growing cells in the presence of moderate concentrations of 
guanidine hydrochloride (GdnHCl), cures cells of most, although not all, prions. Various 
lines of evidence suggest that the essential role of Hsp104 in prion propagation is to 
break apart large aggregates, generating smaller seeding-competent particles that can 
more effectively be partitioned to daughter cells [64-68], but the exact role of Hsp104 in 
the prion process remains controversial [69, 70]. In the case of [PSI+], but not for other 
yeast prions such as [URE3] or [PIN+], Hsp104 overproduction also cures cells of the 
prion; the mechanism by which this occurs is not fully understood [42]. 
In addition to Hsp104, many other yeast chaperones have been implicated in prion 
biogenesis and propagation, though their effects are complex and have been difficult to 
disentangle. Hsp70s are essential, universally conserved chaperones and in yeast, along 
with their obligatory Hsp40 partners, they are necessary for the role of Hsp104 in 
solubilizing protein aggregates. Essential for the activity of Hsp70 are the nucleotide 
exchange factors (NEFs).  Yeast contain 6 different Hps70 chaperone proteins, 2 major 
nucleotide exchange factors and over a dozen Hsp40 chaperone proteins [71, 72]. 
Interestingly, the Hsp70/Ssa1 and Hsp40/Sis1 chaperones appear to influence the 
propagation of most yeast prions [73-77]. However, their exact involvement and role in 
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yeast prion propagation has been very difficult to elucidate as some chaperones promote 
aggregation of one prion while eliminating aggregation of another and sometimes the 
same chaperone has opposing effects even on the same yeast prion depending on the 
chaperone environment of the cell (presence or absence of other chaperones) [77, 78].  
Furthermore, it has been shown that even the nucleotide exchange factors (NEFs) of 
Hsp70 can also influence prion aggregates in yeast [79, 80]. Although the effect of the 
chaperone systems on yeast prions is very complex and not yet fully understood, it is 
clear that chaperones play a crucial role in the maintenance and propagation of yeast 
prions and therefore are intricately linked to prion biology.  
 
PRION STRAIN AND SPECIES BARRIERS 
Although all mammalian prion diseases (TSEs) are mainly characterized by neuronal 
cell loss in the central nervous system and deposition of amyloid plaques, they are very 
variable in their clinical presentation and neuropathological pattern. These differences are 
believed to be due to differences in the PrPSc tertiary structure, and the different 
conformations are considered to be different prion strains. Indeed, the existence of prion 
strains was observed as early as 1961 by Pattison and Millson [81], who found that goats 
infected with the same batch of scrapie agent developed different clinical phenotypes. 
Subsequently, work from a number of different groups has indicated that the same 
protein, PrPC , can adopt different, stable PrPSc  conformations, that in turn define 
different disease phenotypes [82-85].  
Prion strains have also been observed in the case of yeast prions. The best 
characterized examples involve the S. cerevisiae prion protein Sup35. Sup35 is a 
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translation release factor and, in its normal, soluble, non-prion conformation, Sup35 is 
free to carry out its role in efficiently terminating translation in the cytoplasm. In its prion 
form, Sup35 is sequestered in amyloid aggregates and, as a consequence it has a reduced 
ability to efficiently terminate translation resulting in a nonsense suppression phenotype 
referred to as [PSI+][30]. The suppression of nonsense-codon mutations in auxotrophic 
markers is commonly used in yeast to detect the [PSI+] state. More specifically, in yeast 
containing a nonsense mutation in the ade1 gene, [PSI+] colonies are white or pink (and 
can grow in the absence of adenine), whereas [psi-] colonies are red (and require adenine 
to grow).  Studies have shown that different [PSI+] strains can arise in genetically 
identical yeast cells [86]. Along with differences in their mitotic stability and dependence 
on the cellular chaperone machinery, the [PSI+] strains differ in their translation 
termination defects, which in turn can be visualized as differences in the ade1 color 
phenotype [30, 87].  
Additionally, there is evidence to suggest that conformational differences in the 
Sup35 aggregates underlie the different levels of heritable nonsense suppression in 
different [PSI+] strains [86, 88]. Using Sup35 aggregates formed in vitro under different 
conditions, Tanaka et al. showed that the different polymerization conditions resulted in 
distinct Sup35 aggregates, which, when transferred into [psi-] yeast by protein 
transformation (experimental infection), conferred differing nonsense suppression 
phenotypes on the recipient cells [87]. In these experiments, the Sup35 aggregates formed 
at 40C, had different physical properties than the aggregates formed at 230C or 370C, and 
they had a high efficiency of infection with the majority of the colonies showing the 
strong (white) [PSI+] phenotype [87]. The Sup35 aggregates formed at 230C or 370C had 
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instead, low infectivity with almost all the colonies showing the weak (pink) [PSI+] 
phenotype [87]. Additional studies by Diaz-Avalos at al, provided further evidence that 
conformational differences in Sup35 amyloid underlie the differences in the heritable 
nonsense suppression phenotypes of different [PSI+] strains [89]. 
The concept of prion strains has also been used to explain the observation that prion 
infections are typically restricted by species barriers; prion disease transmission is much 
more efficient within the same species than between different species. For example, due 
to a very strong species barrier, there hasn’t been a recorded case of sheep to human 
scrapie transmission. Although PrPC is highly conserved between species, there are a few 
polymorphic positions where different species have different amino acid residues. These 
amino acid differences influence the misfolding propensity of PrPC, as well as the details 
of the misfolded conformation. When a prion strain of one species infects an animal of a 
different species, if the PrPSc agent represents a different misfolded conformation than the 
one favored by the soluble PrPC of the host, the soluble, host PrPC will not convert into 
the prion form and there will be a species barrier to transmission. Nonetheless, in certain 
cases prion stains arise that can breach a species barrier. An example is seen in the human 
prion disease variant vCDJ, which has been experimentally linked to the consumption of 
meat obtained from cattle infected with bovine spongiform encephalopathy [90, 91].   
Barriers to transmission have been described in yeast as well. Using a genetic system 
designed to mimic infection experiments performed with mammalian prions, studies from 
the Weissman laboratory [92] elegantly demonstrated that, although capable of forming 
heritable conformations independently, the prion domains of Sup35 from Saccharomyces 
cerevisiae and Candida albicans are incapable of cross seeding each other.  However, 
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studies from the same lab showed that, a hybrid S. cerevisiae/ C. albicans Sup35 protein 
could “infect” both organisms [93]. Moreover, these workers showed that different amino 
acid substitutions in this hybrid protein affected the tendency of the protein to adopt 
distinct amyloid conformations, which in turn affected the ability of the aggregates to 
“infect” one organism or the other [94]. These experiments served as a model to better 
understand the nature of species barriers and provided further support for the idea that 
conformational differences are the primary determinant of barriers to transmission 
between different species. 
 
BACTERIAL PRIONS? 
Although work conducted over the last decade has uncovered putative prion proteins 
in evolutionarily divergent members of the fungal Kingdom, it is not yet known how 
widespread prions are in nature and more specifically if bacteria contain prions. If such 
proteins exist, bacteria could utilize prion-like aggregates as epigenetic switches that 
could potentially help the cells adapt to a variety of stress conditions. Indeed, a number of 
mechanisms, including phase variation systems and bistable switches, have been 
described that enable isogenic populations of bacteria to exhibit phenotypic diversity. 
These systems are thought to increase the chance of cell survival under adverse 
conditions [95-97]. These processes are reminiscent of the role yeast prions play in 
generating phenotypic diversity in yeast. It is possible that prion formation in bacteria 
may provide another yet-to-be uncovered mechanism for generating phenotypic diversity.  
Although prions have not yet been described in bacteria, non-prion amyloid forming 
proteins have been discovered in many bacterial species. In particular, many bacteria, 
	   15	  
including E. coli, elaborate surface-associated amyloid fibrils that are made up of 
amyloidogenic proteins that are exported to the cell surface where they adopt the amyloid 
fold. These cell surface-associated amyloid fibrils contribute to the formation of biofilms, 
which consist of aggregates of cells embedded in an extracellular matrix consisting of 
polysaccharides, proteins, nucleic acids and lipids useful for surface adhesion and colony 
formation [97, 98]. Because these amyloids play an important role in the formation of 
biofilms, they are referred to as functional amyloids. This term is used to distinguish 
amyloid fibers with defined biological functions from those associated with pathological 
processes.  
In E. coli, these cell surface-associated fibers are known as curli fibers. The curli 
fibers are comprised of the major subunit CsgA and the minor subunit CsgB. Both of 
these proteins have signal sequences to direct their export to the cell surface.  In addition, 
CsgB has a C–terminal sequence that mediates its attachment to the outer membrane and 
from there it templates the amyloid polymerization of CsgA to form the curli fiber. 
Studies have shown that CsgB can form cytoplasmic amyloid if its N-terminal signal 
sequence is removed [99-102].  
 
Yeast prions can access the infectious conformation in E. coli 
While it is not known if bacteria contain prions, whether or not the bacterial 
cytoplasm provides a suitable environment for the formation of prions has been tested. A 
study from this lab has shown that E. coli provides an environment suitable for the 
conversion of the yeast prion Sup35NM domain into the prion form.  This study showed 
that the Sup35NM moiety can access an infectious prion conformation in E. coli cells, 
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and this conversion is dependent on a transplanted [PIN+] factor, the prion form of 
New1p [103]. Specifically, the transfer of cellular protein from the E. coli cells 
containing both Sup35NM and New1 aggregates to [pin-][psi-] yeast cells resulted in 
[PSI+] convertants, demonstrating that the Sup35 aggregates generated in E. coli cells are 
infectious and therefore satisfy the essential criterion that defines a prion. It is striking 
that the conversion of Sup35NM to the prion form in the bacterial cells, like in yeast 
cells, is dependent on the presence of a [PIN+] factor, especially considering the fact that 
bacteria diverged from eukaryotes ~2.2 billion years ago. 
 
FOCUS OF THE DISSERTATION   
The work presented in this dissertation is focused on using E. coli cells as a new 
experimental system for studying prions and their interactions with cellular chaperone 
proteins. The specific focus of this work has been to (i) study the heritability of yeast 
prions in the bacterial environment as well as (ii) identify bacterial chaperones that 
influence amyloid aggregation and potentially prion formation. 
Whereas studies in this lab had already shown that Sup35NM could access the 
infectious prion conformation in the E. coli cytoplasm, we wanted to investigate the 
ability of these prions to be maintained and stably inherited in the E. coli. Using the well-
characterized Saccharomyces cerevisiae yeast prion protein Sup35, we have shown that 
prion aggregates can be maintained for up to 90 generations in the bacterial cytoplasm 
(CHAPTER 2) and that these aggregates are still infectious when transformed into [psi-] 
yeast cells.  
By showing that the bacterial cytoplasm can support the formation and also 
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propagation of infectious prion aggregates, our lab has shown that bacterial cells can 
provide a heterologous system in which to study prion biology. Bacteria encode 
homologs of the chaperones implicated in prion propagation in yeast while at the same 
time containing a reduced number of chaperones compared to yeast [71, 104-106]. For 
these reasons, we believe that E. coli cells provide a simpler system to study the complex 
interaction of prion proteins with cellular chaperones.  It is striking that the conversion of 
Sup35NM to the prion form in the bacterial cells, like in yeast cells, is dependent on the 
presence of a [PIN+] factor.  Based on these similarities, we were interested in exploring 
the effect of bacterial chaperone systems on the formation of prion-like aggregates. In 
fact, studies in yeast have implicated cellular chaperones in the de novo formation of 
[PSI+] [107, 108]. Using the cytoplasmic amyloid aggregation of the curli component 
CsgB as a surrogate for the initial formation of prion-like aggregates, we identified three 
open reading frames in E.coli that, when overexpressed, potentially inhibit cytoplasmic 
amyloid aggregation (CHAPTER 3). 
The work presented in this dissertation demonstrates that E. coli can be used as an 
experimental system to study the behavior of known and putative prion proteins. The 
system we use to study prion heritability in the E. coli cytoplasm can also be used to test 
the effect specific bacterial chaperones have on this process. The demonstration that the 
bacterial environment supports the formation and propagation of the Sup35 prion 
increases our interest in searching for bacterial proteins that may similarly be able to 
function as prions. 
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CHAPTER 2 
	  
	  	  
Propagation of a yeast prion protein in E. coli  	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ABSTRACT	  
	  
Prions are infectious, self-propagating protein aggregates that have been uncovered in 
evolutionary divergent members of the eukaryotic domain of life. However, it is not yet 
known how widespread prions are in nature and, more specifically, if bacteria contain 
prions or even if their cytoplasm provides a suitable environment for prion formation and 
propagation. Here we demonstrate that the E. coli environment can support the 
maintenance of the prion form of a well-characterized yeast prion protein, Sup35. We 
also demonstrate that, like in yeast cells, this process is not dependent on the presence of 
a PIN factor, a distinct prion required for the de novo appearance of the Sup35 prion in 
yeast, but not for its subsequent propagation. Our results indicate that the bacterial 
cytoplasm can be used as a simpler system in which to study the interaction of 
chaperones with yeast prion proteins. 
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INTRODUCTION	  
	  
Prions are infectious, self-propagating protein aggregates that have been associated 
with a number of devastating diseases. Prion aggregates have a characteristic amyloid 
structure, consisting of beta-sheet-rich fibrils, where the beta- strands run perpendicular 
to the fibril axis [1, 2]. In mammals, prions cause fatal neurodegenerative diseases 
referred to as transmissible spongiform encephalopathies (TSEs)[3].  
The discovery of prion forming proteins in fungi and especially yeast cells has led to 
great advances in the understanding of prion biology. Unlike mammalian prions, yeast 
prions do not result in cell death and have even been shown to have physiological 
functions. Furthermore, because they are self-propagating, yeast prions act as protein-
based hereditary elements that are stably maintained from generation to generation.  
The stable maintenance of yeast prions is critically dependent on the cellular 
chaperone network [4, 5]. In particular, studies in yeast have suggested a critical role for 
the Hsp104 chaperone in prion heritability. Hsp104 is a member of the Hsp100 AAA+ 
family of ATPases and, in conjunction with the yeast Hsp70/Hsp40 system, it functions 
to disaggregate and reactivate misfolded proteins in the cell [6, 7]. Evidence suggests that 
the essential role of Hsp104 in prion propagation is to sever large prion aggregates into 
multiple, smaller aggregates that can act as seeds for additional rounds of polymerization 
and can more easily be propagated to daughter cells. However, the exact involvement of 
Hsp104 in the prion process remains controversial [8, 9]. In addition to Hsp104, several 
other yeast chaperones, including the Hsp70/Hsp40 chaperone system, have been 
implicated in prion propagation, although their effects are complex and not well 
understood.  
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A particularly well-characterized prion in Saccharomyces cerevisiae, the [PSI+] prion, 
is formed by the essential translation termination factor Sup35, which assembles into 
amyloid aggregates when it converts into the prion form. Sup35 has a modular structure, 
with the N terminal region containing the essential prion forming domain, the highly 
charged middle region (M) enhancing the solubility of Sup35 in the non-prion form and 
stabilizing the prion form [PSI+], and the C-terminal domain comprising the translation 
termination activity of Sup35 (but not required for its prion behavior) [10]. Studies have 
shown that, when transferred to heterologous proteins, the N and M fragments of Sup35, 
designated NM, confer prion behavior on the resulting fusion proteins [11]. In yeast, the 
de novo appearance of [PSI+] (but not its propagation) is dependent on the prion form of 
yet another prion protein called a [PIN+], for [PSI+] inducibility, factor [12-15]. In yeast 
the New1 and Rnq1 proteins both function as [PIN+] factors.   
In [psi-] cells, Sup35 is soluble and able to properly terminate translation. In [PSI+] 
cells, however, Sup35 is largely sequestered in prion aggregates, resulting in impaired 
translation termination and the suppression of nonsense mutations. The [PSI+] state can 
easily be detected by suppression of nonsense-codon mutations in auxotrophic markers 
[16]. In yeast containing a nonsense mutation in the ade1 gene, [PSI+] colonies are white 
(referred to as strong [PSI+]) or pink (referred to as weak [PSI+]), whereas [psi-] colonies 
are red.  
Although work conducted over the last decade has uncovered putative prion proteins 
in evolutionary divergent members of the fungal Kingdom, it is not yet known how 
widespread prions are in nature and, more specifically, if bacteria contain prions or even 
if their cytoplasm provides a suitable environment for prion propagation. A study from 
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this lab has shown that E. coli can indeed provide an environment suitable for the 
conversion of the yeast Sup35NM domain into the prion form [17], and that conversion 
of the Sup35NM moiety into the prion conformation is dependent on a transplanted 
[PIN+] factor, the prion form of New1 [17]. Specifically, E. coli cells producing both 
Sup35NM and New1 (but not Sup35NM alone) contained material that could induce 
[PSI+] when transferred to yeast cells containing Sup35 in the non-prion form, 
demonstrating that the Sup35NM aggregates generated in E. coli cells are infectious and 
therefore satisfy the essential criterion that defines a prion. However, the ability of the 
infectious Sup35NM aggregates to be propagated and stably maintained in the bacterial 
cytoplasm remains to be investigated. 
Here we show that the Sup35NM prion formed in the bacterial cytoplasm in the 
presence of the transplanted PIN factor, New1, can be maintained in the bacterial 
cytoplasm for close to 90 generations following removal of the PIN factor. These results 
suggest that the bacterial cytoplasm can be used as a heterologous system to study the 
complex interaction of prions and chaperone proteins. 
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RESULTS 
 
The infectious Sup35 prion aggregates can be maintained in the bacterial cytoplasm 
for 30 generations following the shut off of PIN synthesis. 
Whereas studies in this lab have already shown that Sup35NM can access the 
infectious prion conformation in the E. coli cytoplasm, we sought to determine whether 
these prions could be maintained and stably inherited in the E. coli environment. To 
address the question of the heritability of the Sup35NM (hereafter referred to as NM) 
aggregates in the bacterial environment, we took advantage of the fact that, in yeast, the 
[PIN+] factor is required for the de novo appearance of [PSI+], but not for its propagation. 
Our plan was to induce the formation of NM aggregates in E. coli cells also containing 
the New1 prion domain serving as the PIN factor, and then to monitor the propagation of 
the NM aggregates after New1 synthesis was repressed.   
To carry out this experiment, we made use of a plasmid vector directing the 
arabinose-inducible synthesis of an NM-YFP fusion protein and an E. coli strain 
modified to direct the IPTG-inducible synthesis of a New1-CFP fusion protein from the 
chromosome. We grew cells containing the NM-YFP plasmid for about 5 hours in liquid 
culture under inducing conditions for both NM and New1 (in the presence of both 
arabinose and IPTG- hereafter this culture will be referred to as culture A), thus allowing 
the NM aggregates to form. We also grew a control culture containing arabinose but no 
IPTG (hereafter referred to as culture B). 
Following formation of the NM aggregates in culture A, we plated the cells from both 
cultures on medium containing arabinose, but not IPTG, to allow for continued synthesis 
of only the NM-YFP fusion protein (New1-CFP synthesis was shut off). Individual 
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colonies were picked and inoculated into liquid medium for overnight growth. Cell 
extracts were prepared from these overnight cultures and analyzed for the presence of 
NM aggregates by means of semidenaturing detergent agarose gel electrophoresis (SDD-
AGE), a technique that permits the visualization of SDS-stable amyloid polymers. For 
this analysis, bacterial extracts are treated at room temperature with 2% SDS and then run 
through a 1.5% agarose gel containing 0.1% SDS that allows for separation of SDS-
stable polymers from soluble protein. With this method, the SDS-stable polymers are 
visualized as higher molecular weight smears.  The experimental approach is shown in 
Figure 2.1. 
In this experiment, we examined 10 samples derived from the starter culture induced 
for both NM and New1 synthesis (culture A) and 10 samples derived from the starter 
culture induced for NM only (culture B). Of the 10 samples derived from Culture A, 
eight contained NM aggregates (Nr.1, 3, 4, 5, 6, 7, 8, 9) (Fig. 2.2A). None of the cultures 
derived from the Culture B contained detectable NM aggregates. These same samples 
were subjected to Western blot analysis in order to assess fusion protein levels (Figure 
2.2B and 2.2C).  
This initial experiment shows that NM aggregates can be maintained for up to 30 
generations (~20 generations on solid medium plus ~10 generations during overnight 
growth in liquid medium) following the shut off of New1 synthesis. Although there are 
low levels of New1 protein in culture A derivatives due to leaky new1 expression (Fig. 
2.2C), these protein levels are not sufficient to lead to de novo NM aggregation (S. J. 
Garrity, unpublished data). In this experiment, we observed low levels of New1 protein 
only in culture A derivatives, but not in culture B derivatives. However, in a repeat 
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Figure 2.1:  Experimental design for studying prion heritability in E. coli following 
shut off of New1 synthesis. NM aggregates are allowed to form in the bacterial 
cytoplasm in the presence of the New1-CFP fusion protein in Round 0. Cells are then 
grown for 30 generations under conditions that repress New1-CFP synthesis, and then 
analyzed for NM SDS-stable aggregates by SDD-AGE.  
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A.	   
 
 
 
B. 
 
 
 
C.	   
 
 
Figure 2.2:  NM aggregates can be maintained for 30 generations in E. coli in the 
absence of New1. (A) SDD-AGE analysis of cultures from Round 1 of experimental 
design shown in Figure 2.1. This gel image is a composite of separate gels. Lanes 1 and 2 
contain the cultures A and B respectively. The next 10 lanes contain extracts from 
overnight cultures grown from 10 separate Round 1 colonies derived from culture A. 
Eight of these samples (Nr.1, 3, 4, 5, 6, 7, 8, 9) still contained NM aggregates although 
new1 expression had been shut off for 30 generation. The last 10 lanes contain extracts 
from overnight cultures grown from 10 separate Round 1 colonies derived from culture 
B. None of these samples contained detectable NM aggregates. We frequently observe 
signal-producing shapes in the SDD-AGE blots that are not to be confused with higher 
molecular weight aggregates (see signal between lanes 5 and 6 in culture B derivatives). 
We are able to distinguish these signals from real smears corresponding to NM 
aggregates as smears typically follow the contours of the lanes and have distinct edges.  
The blot was probed with an anti-Sup35NM antibody. 
(B) Western analysis of NM protein levels of the samples in (A). As seen from the blot, 
for reasons we do not understand, the NM protein levels vary significantly in the steps 
following Round 0. The blot was probed with an anti-Sup35NM antibody. The top band  
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Figure 2.2 continued 
 
corresponds to the NM-YFP fusion protein. The bands observed below the full-length 
fusion protein represent degradation products. (C) Western blot analysis of New1 protein 
levels of the samples in (A). The blot was probed with anti-HA antibody as the New1 
protein is HA tagged. We still observed residual New1 levels in a subset of the cultures 
where New1 synthesis had been shut off for 30 generations, which we attribute to leaky 
expression of the new1 gene. 
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experiment, low levels of New1 protein were observed in samples from both culture A 
and B derivatives (unpublished data).  
We observed considerable variability in the levels of full-length NM-YFP protein 
between samples from either culture A or B derivatives (Fig 2.2B). We do not fully 
understand the reason for the observed variability in the levels of full-length NM protein, 
which has hampered our ability to study the heritability of the NM aggregates. In 
particular, as the maintenance of prion-like aggregates necessarily depends on the 
uninterrupted synthesis of the corresponding prion protein, our current experimental set-
up does not allow us to draw any conclusion about the stability of the NM prion in the E. 
coli system (see SUPPLEMENT TO CHAPTER 2 for a more detailed analysis of 
variability in the levels of full-length NM protein). 
To determine whether the NM aggregates observed in culture A derivatives represent 
infectious material, we used the material to transform [pin-][psi-] yeast cells and asked 
whether any of the transformed cells were converted to [PSI+]. To carry out this 
experiment, we prepared cell extracts from both starter cultures (+ and – IPTG) to serve 
as positive and negative controls, respectively, as well as from the culture A derivatives 
Nr.4 and Nr.5. We mixed the bacterial cell extracts with a plasmid DNA encoding a yeast 
selectable marker and used them to transform yeast spheroplasts prepared from a [pin-
][psi-] yeast strain. The choice of a [pin-][psi-] yeast strain was crucial as transient 
overproduction of NM in a [PIN+][psi-] yeast strain stimulates conversion to [PSI+][18].  
Following the transformation, we looked for possible [PSI+] transformants among the 
total transformants, which are visible as white colonies on ¼ YPD plates. Candidate 
[PSI+] clones were passaged on guanidine hydrochloride-containing medium and those 
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that were cured (reverted to [psi-]) were scored as [PSI+]. Our analysis showed that the 
extracts from culture A derivatives Nr.4 and Nr.5, samples containing heritable 
aggregates, resulted in 2.39% and 0.4% [PSI+] yeast transformants, respectively, as 
compared to 1.56% [PSI+] yeast transformants in the case of the positive control extract 
from culture A (see Table 2.1). Interestingly, all of the [PSI+] yeast transformants 
observed in this experiment were strong [PSI+] strains [19]. The extract from the starter 
culture grown in the absence of IPTG did not result in any [PSI+] yeast transformants, 
which is consistent with the absence of NM aggregates in this sample. The observed 
conversion frequencies observed in this experiment are consistent with conversion 
frequencies from previous experiments in this lab [17]. These results clearly show that 
infectious NM aggregates can be maintained in the bacterial cytoplasm for up to 30 
generations following the shut off of New1 synthesis. 
 
Heat shock does not have a negative impact on the heritability of the infectious NM 
prion aggregates in the bacterial cytoplasm. 
Because we can observe low New1 levels even in bacterial cultures grown in the 
absence of IPTG due to the leaky new1 expression, we wished to exclude the possibility 
that a low level of New1 synthesis might be required to maintain the NM prion. The plan 
was to induce the formation of NM aggregates in E. coli cells containing the New1 prion 
domain, and then monitor the propagation of the NM aggregates after the new1 gene was 
removed from the system. To carry out this experiment, we took advantage of the fact 
that the new1 gene is inserted in the E. coli genome at the lambda attachment site (attB),  
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Table 2.1: NM aggregates maintained in E. coli in the absence of New1 for 30 
generations are infectious when transformed into yeast cells. Extracts from bacterial 
cultures shown in the table above were used to transform [pin-][psi-] yeast cells. The [psi-
] to [PSI+] conversion percentages for the yeast transformants are shown. Analysis of 
these data by Fisher’s exact test suggests that the observed difference in the frequencies 
of [PSI+] transformants is statistically significant (P<10-3). 
 
 
Bacterial Extract  
% of [PSI+] 
Transformants 
    
Culture A 1.56%  (58/3656) 
Culture B 0% (0/2932) 
Culture A derivative Nr.4 2.39% (93/3892) 
Culture A derivative Nr.5 0.4% (13/3276) 
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enabling us to excise the new1 gene from the chromosome after the initial formation of 
the NM aggregates by providing the enzymes required for the excision reaction (the 
bacteriophage lambda Int and Xis proteins) in trans on a temperature-inducible plasmid 
[20]. Subjecting the bacterial cells carrying this plasmid to a 420C heat shock treatment, 
induces expression of the excision enzymes, which in turn leads to removal of new1 from 
the bacterial chromosome (see Figure 2.3 for modified experimental approach).  
Since the new experimental approach includes a heat shock step, a process known to 
affect protein folding, we first decided to test the effect of this added step on the 
heritability of the NM aggregates. It is important point out that in this preliminary 
experiment the bacterial cells did not carry the plasmid encoding the excision machinery 
and therefore, the new1 gene was not excised. To carry out this preliminary experiment, 
following formation of NM aggregates, we treated two equal aliquots from each of the 
cultures A and B in two different ways. One pair was plated directly on medium 
containing arabinose, but not IPTG, to allow for continued synthesis of only the NM-YFP 
fusion protein but not New1-CFP (Treatment 1). The other pair of samples was subjected 
to a 15-minute heat shock step before being plated on the same medium (Treatment 2). 
For each treatment, we then picked 10 individual colonies derived from each of the 
starter cultures and analyzed their extracts for presence of NM aggregates. In the case 
where cultures A and B were subjected to treatment 1 (Fig. 2.4A), of the 10 samples 
derived from culture A, 5 contained NM aggregates (Nr.1, 3, 4, 7 and 9), while none of 
the cultures derived from culture B contained detectable NM aggregates. In the case 
where cultures A and B were subjected to treatment 2 (Fig. 2.4B), of the 10 samples  
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Figure 2.3:  Experimental design for studying prion heritability in E. coli under 
conditions that permit the removal of the new1 gene. NM aggregates are allowed to 
form in the bacterial cytoplasm in the presence of the New1-CFP fusion protein in 
Round 0. Heat shock then leads to removal of the new1 gene from the bacterial 
chromosome. Cells are grown for 30 generations following new1 removal and then 
analyzed for SDS-stable aggregates by SDD-AGE.  
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A. 
 
 
B. 
 
 
Figure 2.4: Heat shock does not negatively affect the maintenance of NM 
aggregates in E. coli. (A). SDD-AGE analysis of cultures from Round 1 of 
experimental design shown in Figure 2.1 (Cultures A and B were not subjected to a 15-
minute heat shock step before being plated for single colonies). This gel image is a 
composite of separate gels. In the gel, the first two lanes contain cultures A and B, 
respectively. The next 10 lanes contain extracts from overnight cultures grown from 10  
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Figure 2.4 continued  
 
separate Round 1 colonies derived from the Culture A. Five out of ten samples (1, 3, 4, 
7 and 9) contained NM aggregates. The next 10 lanes contain extracts from overnight 
cultures grown from 10 separate Round 1 colonies derived culture B. None of these 
samples contained detectable NM aggregates. The blot was probed with an anti-
Sup35NM antibody. As previously mentioned, we can distinguish the signal present in 
the culture B derivatives, lanes 1 and 2, from bona fide SDS-stable aggregates, because 
this signal does not have distinct edges and does not follow the contours of the lanes. 
(B) SDD-AGE analysis of cultures from Round 1 of experimental design shown in 
Figure 2.1, except that the starter cultures A and B were subjected to a 15-minute heat 
shock step before being plated for single colonies. This gel image is a composite of 
separate gels. In the gel, the first two lanes contain culture A and B. The next 10 lanes 
contain extracts from overnight cultures grown from 10 separate Round 1 colonies 
derived from the culture A. Nine out of ten samples (1-7 and 9, 10) contained NM 
aggregates although these aggregates are represented in weak smears in the extracts of 
lanes 1, 4, 5, 6 and 10. The next 10 lanes contain extracts from overnight cultures 
grown from 10 separate Round 1 colonies derived from culture B. None of these 
samples contained detectable NM aggregates. The blot was probed with an anti-
Sup35NM antibody. For the reasons discussed before, the signal present in lane 1 of the 
culture B derivatives does not represent NM SDS-stable aggregates. 
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derived from culture A, nine contained NM aggregates (Nr.1-7 and 9, 10) (Fig. 2.4B). 
None of the cultures derived from culture B contained detectable NM aggregates. 
This experiment suggests that subjecting the cultures to heat shock does not 
negatively affect the heritability of the NM aggregates. In fact, heat shock correlates with 
a slight increase of the fraction of NM aggregates among the cultures inoculated with 
Round 1 colonies. Specifically, 9 out of 10 colonies contained NM aggregates in the case 
of heat shock treatment compared to 5 out of 10 colonies when we did not subject the 
cultures to heat shock (Fig. 2.4A, B).   
To determine whether heat shock negatively affects the infectious character of the 
NM aggregates observed in culture A derivatives, we used the material from culture A 
derivative Nr.1 (Fig. 2.4B) to transform [pin-][psi-] yeast cells and compared the 
frequency of [PSI+] transformants to the frequency of transformants obtained when using 
material from a sample that had not been subjected to heat shock following formation of 
NM aggregates (culture A derivative Nr.9 in Fig 2.4A). Extracts from culture A and from 
culture B derivative Nr.5 in Fig 2.4B served as positive and negative controls, 
respectively.  
Our analysis showed that heat shock did not seem to negatively affect the infectivity 
of the NM aggregates. Specifically, the frequency of [PSI+] yeast transformants obtained 
using heritable material generated in the absence of the heat shock step (0.5% using 
extract from culture A derivative Nr.9 in Fig 2.4A) was comparable to that obtained when 
using heritable material generated after the heat shock step (0.42% using extract from 
culture A derivative Nr.1 in Fig 2.4B) (Table 2.2). The extract from culture A resulted in  
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Table 2.2: Heat shock does not negatively affect the infectivity of NM aggregates in 
E.coli. Extracts from bacterial cultures shown in the table above were used to transform 
[pin-][psi-] yeast cells. The [psi-] to [PSI+] conversion percentages for the yeast 
transformants are shown. Analysis of these data by Fisher’s exact test suggests that the 
observed difference in the frequencies of [PSI+] transformants is statistically significant 
(P<10-4). 
 
Bacterial Extract  
% of [PSI+] 
Transformants 
    
Culture A 2.4%  (147/6212) 
Culture B derivative Nr.5-Fig 2.4B 0% (0/7748) 
Culture A derivative Nr. 9-Fig 2.4A 0.5% (27/5480) 
Culture A derivative Nr. 1 Fig 2.4B 0.42% (43/10320) 
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2.4% [PSI+] yeast transformants, while the extract from the negative control (culture B 
derivative Nr.5 in Fig 2.4B) did not result in any [PSI+] yeast transformants, which is 
consistent with the absence of NM aggregates in this sample. 
 
The infectious NM prion aggregates are maintained in the bacterial cytoplasm for 
up to 90 generations following PIN excision. 
Having now established that heat shock does not seem to hamper the heritability or 
infectivity of the NM aggregates, we investigated the maintenance of the NM aggregates 
in E. coli following excision of new1 from the chromosome. Note that, in this 
experiment, the starter cultures in Round 0 also contained the plasmid carrying the 
temperature inducible enzymes needed for the removal of new1 from the chromosome. 
To carry out this experiment, we subjected the cells to a 15-minute heat shock to 
induce expression of the plasmid-encoded excision genes. This step allowed for the 
excision of the new1 gene from the bacterial chromosome. We then plated the cells on 
medium containing arabinose, but not IPTG, to allow for continued synthesis of the NM-
YFP fusion protein. Individual colonies were picked and inoculated into liquid medium 
for overnight growth (see Fig. 2.3 for experimental design). In parallel, the same 
individual colonies were tested for loss of the new1 gene by patching them on kanamycin 
containing medium (see Fig. 2.5A). (Note that the cassette containing the new1 gene also 
contains a linked kanamycin resistance marker.) In this experiment, the efficiency of 
new1 gene loss was 50% (4 colonies out of 8 colonies tested), but the loss of new1 was 
much less efficient in a subsequent experiment (see experiment described in Fig. 2.8). 
Cell extracts were then prepared from the overnight cultures grown from the individual 
kanamycin-sensitive colonies and analyzed by Western blot to confirm the absence of the 
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New1-CFP fusion protein (Fig. 2.5B). Our analysis showed that kanamycin sensitivity, 
corresponding to the loss of new1 gene, correlated exactly with loss of any detectible 
New1 protein by Western blot. 
To investigate whether the colonies that lost the new1 gene contain NM aggregates, 
we prepared extracts from the overnight cultures of these individual colonies and 
analyzed them by means of SDD-AGE (Fig. 2.6A). We examined 4 samples derived from 
culture A (following excision of new1) and 3 samples derived from culture B. Of the 4 
samples derived from culture A, two contained NM aggregates (Nr.1 and 4) (Fig 2.6A). 
None of the cultures derived from the culture B contained detectable NM aggregates. 
These same samples were also subjected to Western blot analysis in order to assess the 
NM-YFP fusion protein levels (Fig. 2.6B). We observed considerable variability in the 
levels of full-length NM-YFP protein between samples from either culture A or B 
derivatives as mentioned previously.   
These results suggest that infectious NM aggregates can be maintained in the 
bacterial cytoplasm for up to 30 generations following new1 excision. Additionally, these 
aggregates represent infectious material; when the aggregate-containing extract 
(specifically, culture A derivative Nr.4) was used to transform [pin-][psi-] yeast cells, 
0.32% [PSI+] yeast transformants were obtained and this frequency was consistent with 
the frequency of [PSI+] yeast transformants observed when using extract from culture A 
(0.48% [PSI+] yeast transformants).  
We next sought to determine whether the infectious NM aggregates could be 
maintained for a greater number of generations in E. coli following excision of the new1  
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Figure 2.5: Confirming new1 removal from the chromosome. (A) Confirming new1 
loss by plating on appropriate indicator medium. The new1 gene in the E. coli 
chromosome is closely linked to a kanamycin resistance gene and the excision reaction 
results in the loss of both genes. Thus, kanamycin sensitivity (candidates 5 and 8) 
serves as a surrogate for loss of the new1 gene.  Candidates are numbered clockwise 
with candidate 1 at the 12 o’clock position. Both plates contain arabinose to induce the 
continuing synthesis of the NM-YFP fusion protein; in addition the test plate, but not 
the control plate, contains kanamycin. (B) Confirming the loss of New1 by Western 
analysis. The blot was probed with anti-HA antibody (The New1 protein is HA tagged). 
Lanes 1 and 2 contain cultures A and B, respectively. The next 4 lanes contain extracts 
from overnight cultures grown from 4 separate Round 1 colonies derived from culture 
A, each of which had lost the new 1 gene based on kanamycin sensitivity.  The last 3 
lanes contain extracts from overnight cultures grown from 3 separate Round 1 colonies 
derived from culture B, each of which had similarly lost the new1 gene. 
 
 
 
 
 
 
	   49	  
A.    
                                                             
	  	  	  B.	  	  	  
 
 
Figure 2.6: Results of heritability experiments following new1 removal from the 
chromosome.  (A) SDD-AGE analysis of cultures from round 1 of experimental design 
shown in Figure 2.3. Lanes 1 and 2 contain extracts from culture A and B respectively. 
The next 4 lanes contain extracts from overnight cultures grown from 4 separate Round 
1 colonies derived from culture A, each of which had lost the new 1 gene based on 
kanamycin sensitivity. Two of these samples (1, 4,) still contained NM aggregates 
although new1 has been removed from the chromosome. The last 3 lanes contain 
extracts from overnight cultures grown from 3 separate Round 1 colonies derived from 
culture B, each of which had lost the new1 gene based on kanamycin sensitivity. None 
of these samples contained detectable NM aggregates. The blot was probed with an 
anti-Sup35NM antibody. (B) Western analysis of NM protein levels of the samples in 
(A). The blot was probed with an anti-Sup35NM antibody. The top band corresponds to 
the NM-YFP fusion protein. The bands observed below the full-length fusion protein 
represent degradation products. 
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gene. Our plan was to allow for additional rounds of cell division before analyzing cell 
extracts for presence of NM aggregates. To accomplish this, we restreaked individual 
colonies from Round 1 for single colonies before inoculating them into liquid medium for 
overnight growth. Each restreak increased the total generation number by about 20 
generations (see Figure 2.7 for experimental design).  At each round, we picked 
individual colonies and restreaked them further for single colonies and at the same time, 
inoculated them into liquid medium for overnight growth. Cell extracts were then 
prepared from these overnight cultures and analyzed for the presence of NM aggregates 
by SDD-AGE. This approach allowed us to investigate the presence of NM aggregates at 
about 20-generation intervals following excision of the [PIN+] factor. 
In this experiment, we analyzed 120 colonies in Round 1 for loss of the new1 gene 
and obtained only five consisting of cells that had successfully excised the new1 gene. 
We proceeded with these five Round 1 colonies, passaging them as depicted in Figure 
2.7. We prepared bacterial extracts from overnight cultures grown from Round 1, 2, 3, 
and 4 colonies and analyzed them for presence of NM aggregates. Out of the five original 
Round 1 colonies, one maintained NM aggregates even after the third restreaking event 
(see Fig. 2.8 for SDD-AGE and Western analysis of the extracts prepared from the 
overnight cultures of this colony after each round). In parallel, we also analyzed five 
culture B derivatives that had been confirmed to have lost the new1 gene.  
For reasons we do not currently understand, four of the five Round 1 colonies derived 
from culture A that we examined gave rise to cultures that contained very low levels of 
NM protein (in some cases undetectable) at various stages of the restreaking process. 
This drop in NM protein level correlated with a loss of NM aggregates as assayed by  
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Figure 2.7:  Experimental design for studying prion heritability in E. coli following 
additional rounds of restreaking after new1 removal. NM aggregates are allowed to 
form in the bacterial cytoplasm in the presence of the New1-CFP fusion protein in 
Round 0. Heat shock then leads to removal of the new1 gene from the bacterial 
chromosome. Cells are grown for up to 90 generations following new1 removal and 
extracts are analyzed for SDS-stable aggregates at 20-generation intervals. 	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A. 
 
 
 
B. 
 
 
 
 
 
Figure 2.8: Results of heritability experiments after 3 additional rounds of 
restreaking following new1 removal. (A) SDD-AGE analysis of extracts derived from 
each successive round of restreaking for the Round 1 clone that maintained NM 
aggregates. Lane 1 contains the starter culture A. Culture B is not shown in this gel but 
see Fig. 2.9B for analysis of this culture B. The next 4 lanes contain extracts from 
overnight cultures inoculated with individual colonies from Rounds 1-4 of the one 
sample that maintained the NM aggregates following all additional rounds of 
restreaking. The next lane, labeled 4a, contains extract from an overnight culture 
inoculated with another colony from the same Round 4 plate used to inoculate the for 
extract 4 culture. The last two lanes, labeled culture B derivative, contain a 1:10 and a 
1:20 dilution of the extract from the overnight culture of a culture B derivative from 
Round 4. We ran dilutions of this extract because, as seen by the Western Blot analysis 
in (B), this sample had considerably more protein than the other samples loaded on the  
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Figure 2.8 continued 
 
same gel. This extract contained no detectable NM aggregates. The blot was probed 
with an anti-Sup35NM antibody. (B) Western analysis of extracts examined in (A). 
This gel image is a composite of separate gels. The first 4 lanes contain extracts from 
overnight cultures inoculated with individual colonies from Rounds 1-4 of the one 
sample that maintained the NM aggregates following all additional rounds of 
restreaking. The next lane, labeled 4a, contains extract from an overnight culture 
inoculated with another colony from the same Round 4 plate used to inoculate the 
extract 4 culture. The last lane, labeled culture B derivative, contains extract from the 
overnight culture of a culture B derivative from Round 4. As seen, this extract 
contained significantly more NM full-length protein than the rest of the samples. 
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SDD-AGE. For some of these clones, the amount of NM protein increased to high levels 
in the following rounds of restreaking, but NM aggregates were no longer observed (see 
SUPPLEMENT to CHAPTER 2 for SDD-AGE and Western blot analysis of extracts 
from the culture A and B derivatives from each stage of the experimental approach 
shown in Figure 2.7).  
To investigate whether the NM aggregates from Rounds 1-4 shown in Figure 2.8A 
represent infectious material, we used the material to transform [pin-][psi-] yeast. Our 
analysis showed that, although the percentage of [PSI+] yeast transformants varied from 
less than 1% to ~5% when using bacterial extracts obtained from different rounds, NM 
aggregates from each of the rounds represented infectious material (see Table 2.3). The 
extract from culture A resulted in 0.69%  [PSI+] yeast transformants, while the extract of 
the culture serving as a negative control, the extract of a culture B derivative from Round 
4, did not result in any [PSI+] yeast transformants. Interestingly, here we observed weak 
as well as strong [PSI+] strains among the [PSI+] yeast transformants [19].  
These results indicate that once formed in the presence of New1 aggregates, NM 
aggregates can be maintained in the E. coli cytoplasm for about 90 generations following 
new1 excision. Moreover our findings indicate that these NM aggregates correlate with 
the presence of infectious material that is capable of converting [pin-][psi-] yeast cells to 
[PSI+]. 
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Table 2.3:  Infectivity of NM aggregates maintained in E. coli for 3 additional 
rounds of restreaking following new1 removal from the chromosome. Extracts from 
bacterial cultures shown in the table above were used to transform [pin-][psi-] yeast cells. 
The [psi-] to [PSI+] conversion percentages for the yeast transformants are shown. The % 
[PSI+] weak and strong shown in the table are obtained by dividing the number of weak 
or strong [PSI+] transformants by the total number of transformants. The total % [PSI+] is 
obtained by adding the number of weak and strong [PSI+] transformants and dividing by 
the total number of transformants. Analysis of these data by Fisher’s exact test suggests 
that the observed difference in the frequencies of [PSI+] transformants is statistically 
significant (P<10-2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bacterial Extract	  
Total	  	  
Nr.	   Weak	  [PSI+]	  Nr.	   Weak	  [PSI+]	  %	  Strong	  [PSI+]	  Nr.	  Strong	  	  [PSI+]	  %	   Total	  %	  	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Culture	  A	   3048	   0	   0.00	   21	   0.69	   0.69	  
Culture	  A	  derivative-­‐	  
Round	  1	   9000	   15	   0.17	   43	   0.48	   0.64	  
Culture	  A	  derivative-­‐	  
Round	  2	   3698	   8	   0.22	   66	   1.78	   2.00	  
Culture	  A	  derivative-­‐	  
Round	  3	   3048	   31	   1.02	   138	   4.53	   5.54	  
Culture	  A	  derivative-­‐	  
Round	  4	   2720	   15	   0.55	   65	   2.39	   2.94	  
Culture	  A	  derivative-­‐	  
Round	  4a	   1800	   21	   1.17	   50	   2.78	   3.94	  
Culture	  B	  derivative-­‐	  
Round	  4	   1200	   0	   0	   0	   0	   0	  
Plasmid	  Alone	   3232	   0	   0	   0	   0	   0	  
Buffer	   0	   0	   0	   0	   0	   0	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Table 2.4 Plasmids and strains used for this study 
 
Strain/Plasmid Relevant Characteristics Source 
	  
Plasmid 
  
   
pSG241 bla PBAD sup35NMWT-yfp pBR322 ori;  produces 
Sup35NMWT(residues 1-253) fused to YFP 
[17] 
pSG378 URA3 pACYC184 ori cat CEN6; shuttle vector pRS316 
modified to contain pBR322-compatible origin and 
chloramphenicol resistance 
[17] 
pEN184 cat lambdacI857 (ts) lambda pR-xis lambda in repA101 
(ts) oriR101; pAH57 modified to contain chloramphenicol 
resistance 
This study 
   
Strain (Escherichia coli)   
   
SG811 BW27785 attB::ahp lacIq Ptac new150-100-cfp-3xha; 
produces New1 (residues 50-100) fused to CFP and 3 HA 
tags from a chromosomal construct integrated at lambda 
attachment site 
[17] 
   
Strain (Saccharomyces 
cerevisiae) 
  
   
SG775 YJW187 [pin-]; derived by serial passage on YPD with 
3mM GuHCl; phenotypically [pin-] [psi-]; 
[17] 
SG861 YJW187 [PSI+]; phenotypically weak [PSI+] [17] 
SG862 SG775 [PSI+]; phenotypically strong [PSI+] [17] 
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DISCUSSION 	  
 The experiments presented in this chapter have demonstrated that the E. coli cellular 
environment supports the propagation of the prion form of the yeast Sup35 protein (its 
prion-forming domain, NM, in particular). NM aggregates formed in the presence of the 
PIN factor can be maintained in the bacterial cytoplasm for close to 90 generations 
following removal of PIN from the system, and these aggregates are infectious when used 
to transform yeast. It is interesting that the relation of PIN to NM aggregates in bacteria 
recapitulates the relationship in yeast with respect to both NM aggregate formation and 
aggregate propagation; namely, PIN is required for the de novo appearance of [PSI+] but 
not for its propagation.  
 In yeast cells, once formed, the [PSI+] prion is stably maintained. However, the 
stability of the NM prion aggregates formed in the bacterial cytoplasm remains to be 
investigated. At the present time, the fluctuation in the NM-YFP protein levels 
throughout the course of the experiment hampers our ability to investigate the stability of 
NM prion aggregates in the bacterial cytoplasm. Due to this problem, the system we use 
to study yeast prion heritability in the bacterial cytoplasm will need to be modified before 
the stability of NM aggregate propagation in E. coli can be assessed.  To accomplish this, 
we suggest using a different induction system for NM gene expression, one that results in 
consistent NM protein levels throughout the experiment and is reproducible from 
experiment to experiment. In addition to answering the question of the stability of NM 
aggregates in E. coli, the new system would allow us to search for mutants that either 
increase or decrease the observed stability of the NM aggregates in E. coli.  
	   58	  
 Additionally, the system we employ to remove new1 from the chromosome following 
formation of NM aggregates is not very efficient. In certain instances, the new1 removal 
efficiency can be as low as 4% (see experiment described in Fig. 2.8), thus limiting the 
number of bacterial colonies we can analyze for heritable NM aggregates. To address this 
limitation, we suggest redesigning the system to provide new1 on a plasmid with a 
temperature sensitive replicon that should allow for easy removal once the NM 
aggregates have formed.  
 Despite all the problems and limitations with the current system, we have shown that 
it is possible for infectious NM aggregates to be maintained for 90 generations in the 
bacterial environment. The general model developed to study prion heritability in the E. 
coli cytoplasm could also be used to test the effect specific bacterial chaperones have on 
this process. Preliminary work by a former member of our lab, Dr. Sean Garrity, has 
indeed shown that changes in the bacterial chaperone environment can alter the nature of 
the NM aggregates that are formed. Specifically, overproduction of ClpB, the Hsp104 
bacterial homolog, not only seems to reduce the average size of the Sup35NM polymers, 
but it also seems to increase the infectivity of such aggregates (S. J. Garrity, unpublished 
data).  
 Based on these preliminary results, it is of great interest to examine how bacterial 
chaperones influence the heritability of yeast prions formed in the bacterial cytoplasm. In 
fact, in preliminary experiments we have found that heat shock, which upregulates the 
production of many chaperones, seems to increases the heritability of the Sup35NM 
aggregates in E. coli (see Fig. 2.4).  
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The results of the experiments described in this chapter set the stage for examining 
the interaction of bacterial chaperones with yeast prion proteins and more specifically for 
determining how bacterial chaperones influence prion propagation. 
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MATERIALS AND METHODS 
Plasmids, Strains and Cell growth 
Bacterial cultures were grown overnight and then diluted to OD600 0.02 in LB 
supplemented with the appropriate antibiotics (Carbenicillin 100 µg/ml; Chloramphenicol 
25 µg/ml, Kanamycin 50 µg/ml), grown for 30 minutes at 300C and induced with the 
appropriate inducers (L-Arabinose at 0.0002% w/v; IPTG at 1mM) for about 5 hours. For 
the experiment described in Figure 2.8 following addition of inducers the cultures were 
grown overnight and the next day the culture were diluted tenfold and grown for about 
2.5 hours in the presence of the appropriate antibiotics and L-Arabinose at 0.0002% w/v. 
Following heat shock, the cultures were plated for single colonies on plates supplemented 
with carbenicillin (100 µg/ml) and L-Arabinose (0.0002% w/v) and grown at 370C for 
efficient loss of the pEN184 plasmid. Additional restreaks as shown in Figure 2.7 were 
grown at 300C. 
The NM-YFP construct was produced from pBR322-derived plasmids under the 
control of the arabinose-inducible promoter pBAD. The New1-CFP-3xHA was integrated 
in the chromosome and was produced under the control of an IPTG inducible promoter. 
 
Bacterial Extract Preparation 
50ml or 5ml cultures were grown to the indicated times and the OD600 was recorded. 
Bacterial extracts were then prepared as described [17] with the following modifications. 
Cell debris was removed from the lysate by centrifugation for 10 minutes at 500 x g at 
40C. Lysates were normalized for total protein as assayed by bicinchoninic acid 
(ThermoFisher). 
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Semi-Denaturing Detergent Agarose Gel Electrophoresis 
SDD-AGE was performed as described [21] using 1.5% agarose. Blots were probed 
with anti-HA (clone 3F10; Roche), anti-Sup35 yS-20 (Santa Cruz Biotechnology). 
Secondary antibodies were horseradish peroxidase (HRP)-conjugated anti-rat IgG 
(Abcam ab6734), and protein G (Abcam ab7460). Blots were detected using ECLplus 
Western Blotting Detection System (GE Healthcare). 
 
Protein Extract Transformations 
25 µl of bacterial or yeast extract was used to transform 100 µl of [pin-][psi-] yeast 
spheroplasts as described [17] (and reference therein [22]). [PSI+] transformants were 
scored as described [22].  
 
Bacterial and Yeast Fusions 
Fusion of bacterial protoplast to [pin-][psi-] yeast spheroplasts was performed as 
described elsewhere [17] (and references therein [22, 23] 
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RESULTS AND DISCUSSION 
The arabinose inducible system results in fluctuating levels of full-length NM 
protein from colony to colony as well as in the same clone over successive rounds of 
restreaking.	  
 In the work presented in this Supplement, we follow the full-length protein levels and 
aggregative state of the NM-YFP fusion protein through the 3 rounds of restreaking 
shown in Fig.2.7. The samples shown in Fig. 2.8 of this CHAPTER were a subset of 
those discussed here.   As described above, after the growth of starter cultures A and B 
(and the formation of NM aggregates in culture A), we subjected the cells to a 15-minute 
heat shock to induce the plasmid-encoded enzymes needed for the removal of new1 from 
the bacterial chromosome.  We then plated the cells on medium containing arabinose for 
the continued expression of the NM-YFP fusion protein and picked individual colonies to 
test for the loss of new1. We obtained 5 derivatives from each of the starter cultures that 
were confirmed to have lost the new1 gene. We then carried these derivative colonies 
through the remaining rounds of the experimental design shown in Fig. 2.7 and analyzed 
cell extracts prepared after each round of restreaking by means of SDD-AGE and 
Western analysis for NM aggregates and protein levels, respectively.  
 Our analysis showed that in Round 1, only three (Nr.3, 4 and 5) of the 5 culture A 
derivatives contained detectable full-length NM protein and all three of these cultures 
contained NM aggregates as detected with SDD-AGE (Fig. 2.9A). Although culture A 
derivative Nr.1 contained NM aggregates and therefore must contain full-length NM 
protein, we did not detect the protein in our Western blot experiment.  
 
	   68	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B. 
	  	  	  	  	  	  	  
 
 
Figure 2.9 Arabinose induction results in varying NM-YFP full-length protein levels 
from colony to colony and in the same clone over time. 
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Figure 2.9 continued 
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Figure 2.9 continued 
  
 
(A) Western blot (top panel) and SDD-AGE analysis (bottom panel) of cultures from 
Round 1 of experimental design shown in Figure 2.7. The first 5 lanes contain extracts 
from overnight cultures grown from 5 separate Round 1 colonies derived from culture A. 
The last 5 lanes contain extracts from overnight cultures grown from 5 separate Round 1 
colonies derived from culture B. None of the culture B derivatives contained detectable 
NM aggregates. The blots were probed with an anti-Sup35NM antibody. (B) Western 
blot (top panel) and SDD-AGE analysis (bottom panel) of cultures from Round 2 of 
experimental design shown in Figure 2.7. Lanes 1 and 2 contain extracts from cultures A 
and B, respectively. The next 5 lanes contain extracts from overnight cultures grown 
from 5 separate Round 2 colonies derived from culture A. The last 5 lanes contain 
extracts from overnight cultures grown from 5 separate Round 2 colonies derived culture 
B. None of the culture B derivatives contained detectable NM aggregates. The blots were 
probed with an anti-Sup35NM antibody. (C) Western blot (top panel) and SDD-AGE 
analysis (bottom panel) of the same cultures as in (A) and (B), but from Round 3 of 
experimental design shown in Figure 2.7. (D) Western (top panel) and SDD-AGE 
analysis (bottom panel) of the same cultures as in (A), (B) and (C), but from Round 4 of 
experimental design shown in Figure 2.7.  
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Only two (Nr.1 and 3) out of the 5 culture B derivatives contained detectable full-length 
NM protein, but neither of them contained any detectable aggregates.  
In analyzing extracts from Round 2 (Fig. 2.9B) we observed that the pattern of full-
length NM expression of the bacterial clones differed from the one seen in Round 1. For 
instance, culture A derivatives Nr.3, 4 and 5 still contained high levels of NM protein and 
also NM aggregates, but culture Nr.2 also had some detectable full-length NM protein, in 
contrast to what we saw in Round 1. However, this culture did not contain any NM 
aggregates in Round 2, possibly due to the fact that protein synthesis was interrupted in 
Round 1. Moreover, the PIN factor had been removed from the system and therefore no 
de novo NM aggregation could occur. Culture A derivative Nr.1 had also lost the NM 
aggregates in Round 2, possibly due to the fact that the very low levels of NM protein 
were not sufficient to support aggregation.  Culture B derivatives Nr.2 and 4 now had 
detectable full length NM in addition to the cultures Nr.1 and 3. However, as expected, 
none of these cultures contained any detectable NM aggregates. 
In Round 3 (Figure 2.9C), culture A derivatives Nr.1 and 2 contained detectable 
levels of NM protein, but as expected this upregulation in NM protein levels did not 
correlate with reappearance of NM aggregation due to the absence of PIN factor. Culture 
A derivatives Nr.3 and 5 still maintained high NM levels and the associated aggregates 
(though the signal was faint for culture Nr.5).  However, culture A derivative Nr.4  no 
longer contained any detectable full-length NM protein, and it had also lost the NM 
aggregates. The protein levels for the culture B derivatives also had a slightly different 
pattern in this Round than the pattern seen in Round 2. 
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Finally, in Round 4 (Figure 2.9D), only culture A derivative, Nr.3, contained high 
levels of NM protein and the associated NM aggregates. Culture Nr.5 contained low 
levels of full-length NM and it no longer contained detectable NM aggregates, possibly 
due to the decrease in NM-YFP protein levels. 
This experiment clearly shows that the current, arabinose inducible system is not 
optimal for the study of prion heritability in the bacterial cytoplasm. The observation that 
NM protein levels in the same clone can fluctuate significantly from round to round, 
sometimes even dropping below levels necessary to maintain an aggregated state, makes 
it impossible to draw conclusions about the stability of NM aggregate propagation in the 
E. coli system. We believe that the observed number of clones able to maintain NM 
aggregates through all four rounds of our experimental design is probably an 
underestimate, as some colonies lost the aggregates in the course of the experiment due to 
the interrupted synthesis of the NM-YFP fusion protein.  
We obtained additional information about the conditions that lead to fluctuations in 
NM protein levels in the course of another experiment that was performed, in part, to 
investigate the effect of culture dilution on the NM-YFP protein levels. Previous 
evidence from the lab had suggested that dilution into fresh medium appeared to 
downregulate the synthesis of the NM-YFP fusion protein (S. J. Garrity, pers. comm.), an 
observation we wished to follow up on.  
For this experiment, we grew bacterial cultures under inducing conditions for both 
NM and New1 for about 6 hours to an OD of 2 and then diluted the culture ten-fold into 
fresh medium supplemented with arabinose only for the continued induction of the NM 
fusion protein. As a result, the concentration of arabinose in the diluted culture remained 
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identical to that of the initial culture, while the concentration of the New1 inducer, IPTG, 
was reduced ten-fold. (We anticipated that this 10-fold reduction in IPTG concentration, 
from 1 mM to 100 µM, would still leave enough IPTG in the culture to fully induce 
expression of the New1 fusion protein.) We analyzed extracts from both the initial and 
the diluted cultures for NM-YFP and New-CFP protein levels by means of a Western 
blot. 
The Western blot revealed that the New1-CFP protein levels remained unchanged in 
the two cultures despite the IPTG concentration in the diluted culture being 1/10 of the 
concentration of the initial culture (see Figure 2.10B). However, we noticed a significant 
drop in the levels of the NM-YFP fusion protein in the diluted culture as compared to the 
initial culture even though the arabinose concentration did not change (see Figure 2.10A).  
This experiment suggests that dilution into fresh medium results in a specific 
downregulation of NM-YFP levels. This observation suggests that, when passaged into 
fresh medium in the course of our experiment, the NM protein levels can initially drop to 
levels that may be insufficient for aggregate maintenance. Even if the NM protein levels 
are subsequently upregulated in the same culture, the NM aggregates would be 
irreversibly lost. In our experimental set-up, we routinely analyze liquid cultures for NM 
protein levels and NM aggregates at the end of their overnight growth, and although we 
sometimes notice high NM protein levels at this stage, we do not know the history of 
these protein levels during the course of the growth of the culture. Therefore, lack of 
aggregates even in the presence of high NM protein levels, could be due to the 
interruption of NM-YFP protein synthesis at some point during growth. 
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A.                                                                   B.	  	  
             
 
Figure 2.10 Dilution into fresh medium leads to a drastic reduction in NM-YFP 
protein levels but does not affect the New1-CFP protein levels. (A) Western analysis 
of NM-YFP levels in a dilution culture as compared to initial culture. NM-YFP levels 
dropped significantly when the culture was diluted into fresh medium although the 
inducer concentration remained unchanged. The blots were probed with an anti-
Sup35NM antibody. (B) Western analysis of New1-CFP levels in a dilution culture as 
compared to initial culture. New1-CFP levels remained unchanged in the dilution 
culture although the inducer concentration dropped ten-fold when diluted. The blots 
were probed with an anti-HA antibody. 
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For the reasons discussed here, we believe that our system needs to be redesigned in 
order to study the stability of yeast prions in bacteria. We believe that using a different 
induction system for the NM-YFP fusion protein would eliminate the problem of 
fluctuating protein levels. Our analysis indicates that an IPTG inducible system results in 
a more reproducible and consistent protein synthesis  (Fig. 2.10) and as a result might be 
better suited for the production of the NM-YFP fusion protein in the experimental set-up 
used to study yeast prion heritability in E. coli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   76	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
CHAPTER 3 
	  
	  
 
Identifying cellular factors that influence amyloid formation in E. coli 	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ABSTRACT	  
By showing that the bacterial cytoplasm can support the formation and maintenance 
of infectious prion aggregates, studies from this lab have shown that the bacterial cells 
can serve as a heterologous system in which to study prion biology.  In yeast, cellular 
chaperones have been implicated in the de novo formation of prion aggregates, but the 
effect of the bacterial chaperone system on the formation of prion amyloids remains to be 
investigated. Using the non-prion, amyloid forming bacterial protein CsgB as a model 
protein, we have identified three E. coli open reading frames that, when overexpressed, 
potentially inhibit the formation of amyloid aggregates in the bacterial cytoplasm. The 
work presented here further supports the use of E. coli as a model system in studying the 
behavior of known and putative prion proteins. 
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INTRODUCTION	  
Prions are infectious, self-propagating protein aggregates with a characteristic 
amyloid structure made up of beta-sheet-rich fibrils, where the beta-strands run 
perpendicular to the fibril axis [1, 2]. Prions were first described in mammals, where they 
cause a group of devastating neurodegenerative disorders called the transmissible 
spongiform encephalopathies. Subsequent work uncovered a prion-like phenomenon in 
yeast and other fungi. However, unlike mammalian prions, yeast prions do not result in 
cell death, but rather have been shown to act as protein-based hereditary elements that are 
stably maintained from generation to generation.  
The discovery of prion forming proteins in yeast has dramatically improved our 
understanding of prion biology. Studies in yeast have shown that propagation of prion 
aggregates is critically dependent on the cellular chaperone machinery and specifically on 
the hexameric AAA+ ATPase Hsp104 [3, 4]. This chaperone is thought to mediate the 
propagation of prion aggregates from generation to generation by breaking large 
aggregates into smaller units than can easily be passed on to daughter cells [5]. Deletion 
of Hsp104 results in a loss of the prion aggregates and their related phenotypes in yeast. 
In the case of Sup35, the best-characterized prion forming protein in yeast [6], 
overproduction of Hsp104 also results in a loss of the prion-associated phenotype, 
presumably due to the complete disaggregation of prion aggregates by Hsp104 [7, 8]. 
However, curing of the prion state by overproduction of Hsp104 has been observed only 
in the case of the Sup35 prion, but not in the case of other well-studied yeast prions [6].  
Studies in yeast have also revealed a role for other cellular chaperones, including Hsp 
40 and Hsp 70, not only in the process of prion propagation, but also in the de novo 
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appearance of prions [9-15]. However, the precise mechanisms by which these 
chaperones influence prion behavior in yeast have been very difficult to elucidate partly 
due to the fact that the same chaperone can have opposing effects on different prions and 
sometimes even on the same prion depending on the presence or absence of additional 
yeast chaperones [16, 17]. Dissection of the interactions of the yeast chaperone systems 
with yeast prions is also complicated by the fact that yeast cells encode several different 
proteins for each class of chaperones. 
Although it is not yet known if bacteria contain prions, bacteria provide a potentially 
useful experimental system in which to study the behavior of known and putative prion 
proteins. Indeed, work from this lab (reference [18] and work presented in CHAPTER 2) 
has shown that the bacterial cytoplasm can support formation and even maintenance of 
yeast prions. Moreover, bacteria encode the homologs of chaperones shown to have an 
effect on prion behavior in yeast, and conveniently contain a reduced number of 
redundant chaperones and regulators compared to yeast. In addition, non-prion, amyloid-
forming proteins have already been described in bacteria [19], though all known 
examples aggregate extracellularly, where they contribute to physiological functions such 
as biofilm formation, host colonization, cell invasion, and immune activation.  
Under appropriate conditions, E. coli and Salmonella species elaborate cell surface-
attached amyloid fibers known as curli that are an important structural constituent of 
biofilms. Unlike the production of disease-associated amyloids, curli fiber formation is 
not the result of protein misfolding but instead depends on a dedicated and highly 
controlled pathway. In E. coli, there are at least 7 proteins involved in curli formation and 
they are encoded by the two divergently transcribed operons csgBAC and csgDEFG. 
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CsgD is the master regulator of curli biogenesis and it is essential for the transcription of 
the csgBAC operon [20], which encodes the major and minor components of the fiber, 
CsgA and CsgB, respectively [21]. CsgG is secreted into the periplasm via its Sec signal 
sequence and from there it is transported into the outer membrane, where it polymerizes 
to form the pore required for the export of CsgA and CsgB into the extracellular space 
[22]. Like the other curli proteins, CsgA and CsgB are secreted into the periplasm via the 
Sec translocon. From there, with the help of the three additional curli proteins CsgC, 
CsgE and CsgF, they are directed through the CsgG pore to the extracellular space [20, 
22, 23]. A C–terminal sequence in CsgB mediates its insertion into the outer membrane, 
and from that position, CsgB templates the amyloid polymerization of the freely secreted 
CsgA [24].  
CsgB can also form cytoplasmic amyloid if its N-terminal signal sequence (Sec signal 
sequence) is removed [19, 25]. Studies by Dr. Sean Garrity, a former graduate student in 
our lab, demonstrated that when fused to the CI protein of bacteriophage lambda (λCI; 
the lambda repressor) and produced in the cytoplasm, CsgB causes cell toxicity, which 
correlates with the ability of the CsgB moiety to form amyloid-like aggregates (a 
mutation in the CsgB moiety that impedes amyloid conversion relieves this toxicity) (S.J. 
Garrity, unpublished data). A sequence-specific DNA-binding protein that binds 
cooperatively to adjacent and non-adjacent operators on the phage chromosome, λCI can 
also bind to lower affinity operator-like sequences on the bacterial chromosome when 
overproduced. Subsequent work by a postdoc in the lab, Dr. Viknesh Sivanathan, 
indicated that the toxicity of the λCI-CsgB fusion protein was also relieved by mutations 
in the λCI moiety that abolish cooperative DNA binding (V. Sivanathan, unpublished 
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data), suggesting that the toxicity of the fusion protein is due to both its amyloidogenicity 
and its non-specific DNA binding activity.  
Here, we take advantage of the toxicity of the λCI-CsgB fusion protein to design a 
selection system that allows us to identify open reading frames that influence amyloid 
formation in E. coli. Using relief of toxicity as a readout of decreased aggregating ability, 
we identified three open reading frames in E. coli that, when overexpressed, potentially 
affect cytoplasmic amyloid formation. We outline further experiments that could be 
performed to better characterize the effects of the proteins encoded by these open reading 
frames.  
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RESULTS 
Selection system used to identify bacterial factors that influence amyloid formation 
in E. coli and identification of candidate ORFs. 
Since work from this lab had already shown that the bacterial cytoplasm could 
support the formation and propagation of prion aggregates, we were interested in 
studying the effect of the bacterial chaperone system on the formation of prion amyloids. 
In fact, studies in yeast have implicated cellular chaperones in the de novo formation of 
the Sup35 prion, known as [PSI+][12, 13]. In our study, we used the amyloid aggregation 
of the curli component CsgB as a surrogate for the initial formation of prion-like 
aggregates. 
As mentioned above, we took advantage of the cell toxicity of a λCI-CsgB fusion 
protein to design a selection system to identify cellular factors that affect amyloid 
formation in E. coli. Using relief of toxicity as readout of decreased aggregating ability, 
we tested the effect of overexpressing a library of E. coli ORFs on the ability of the λCI-
CsgB fusion protein to access the amyloid conformation (see Figure 3.1 for experimental 
approach). To carry out this selection, we transformed a plasmid encoding the λCI-CsgB 
fusion protein under the control of an IPTG-inducible promoter into the E. coli ASKA 
library, where each cell harbors a mobile plasmid carrying one of the 4300 E. coli ORFs 
also under the control of an IPTG-inducible promoter [26, 27]. We plated the 
transformants onto medium supplemented with the appropriate antibiotic and 125µM 
IPTG to induce the synthesis of both the λCI-CsgB fusion protein and the protein 
encoded on the mobile plasmid. Using control strains from the ASKA library, we had 
already shown that the plating efficiency of cells transformed with the λCI-CsgB plasmid  
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Figure 3.1:  Experimental design for identifying ORFs that affect amyloid 
formation E. coli. Aggregation of the λCI-CsgB fusion protein results in cell 
toxicity. Overexpression of an ORF inhibiting amyloid formation will result in relief 
of the amyloid mediated toxicity.	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was 1/1000 to 1/3000 in the presence of 125µM IPTG, whereas the plating efficiency of 
cells transformed with an aggregation deficient version of the λCI-CsgB fusion protein 
(λCI-CsgB Q117R; S.J. Garrity, unpublished data) was ~1 (see Figure 3.2).	  
We identified 40 surviving colonies out of 13,000 transformants plated and restreaked 
them on IPTG containing plates to confirm the relief of toxicity.  Out of the 40 surviving 
colonies, only 13 were confirmed by the restreak. Then, using universal primers that 
annealed to the backbone of the plasmid carrying the individual ORFs, we amplified and 
sequenced the ORF being expressed in each of the surviving colonies. Using this method 
we identified 6 different ORFs present in the surviving colonies. To confirm that the 
ORFs being expressed in these clones did indeed relieve the toxicity of the fusion protein, 
we re-transformed the λCI-CsgB plasmid into the ASKA strain carrying the specific ORF 
identified in the initial selection. We were able to do this only for 5 out of the 6 ORFs 
identified, as we did not have access to the ASKA strain carrying one of the identified 
ORFs. Only 3 of the 5 identified E. coli ORFs relieved the toxicity of the fusion protein 
when re-tested in this manner (see Table 3.1 and Figure 3.3). 	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Figure 3.2: λCI-CsgB causes cell toxicity starting at an IPTG concentration of 
125µM. The JA200 strain overexpressing the ycfD open reading frame, transformed with 
either the λCI-CsgB or the λCI-CsgB Q117R plasmid, and grown on plates with the 
indicated IPTG concentration. As seen, the λCI-CsgB plasmid causes cell toxicity at an 
induction level of 125µM IPTG, whereas the λCI-CsgB Q117R plasmid does not. 
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Table 3.1:  A list of the clones obtained in the selection using relief of toxicity as a 
readout of decreased aggregating ability. The table indicates the name of the selected 
clone, the name of the ORF overexpressed in that clone and a description of the ORF.  	   	  	  	  	  	  	  
 	  
 
 
 
 
 
 
 
 
 
 
 
 
Clone Name ORF Name Function of ORF 
   
MOB-8 mhpC 
2-hydroxy-6-ketonona-2,4-dienedioate 
hydrolase  
MOB-12 ydjO Predicted protein 
MOB2-27 yrhA Conserved Protein 
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Figure 3.3:  Reconfirmation of toxicity relief by ORFs identified in the selection. The 
ASKA clones overexpressing the ORF identified in the initial selection were re-
transformed with the λCI-CsgB plasmid and grown on medium lacking or containing  
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Figure 3.3 continued 
 
IPTG. As seen, the ORFs identified in the selection relieve λCI-CsgB-induced toxicity. 
Shown are the results for (A) mhpC, (B) ydjO, (C) yrhA and (D) a control ORF, yciE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   90	  
Initial validation of candidate ORFs 
One possible way for the candidate ORFs identified in our selection to relieve λCI-
CsgB-mediated toxicity would be to cause a drop in fusion protein levels (either by 
downregulating fusion protein synthesis or by destabilizing the fusion protein). In this 
scenario, the relief of toxicity would merely be due to the fact that the intracellular 
concentration of fusion protein is too low to permit sufficient amounts of amyloid 
material to form. To determine whether the ORFs identified in our selection relieve 
toxicity by altering fusion protein levels, we compared the λCI-CsgB levels in cells 
overexpressing the identified ORFs to those in cells overexpressing a control ORF that 
did not relieve fusion protein toxicity. It was also essential that the control ORF chosen 
did not cause cell toxicity on its own, in the absence of λCI-CsgB.  
We could not carry out this experiment simply by culturing the cells in the presence 
of IPTG (to maintain synthesis of both the λCI-CsgB fusion protein and the ORF-
encoded protein) because, whereas bacterial cultures containing one of the selected ORFs 
would grow normally under these conditions, the cultures overexpressing the control 
ORF would not since the aggregation of the λCI-CsgB fusion protein would cause cell 
toxicity. To solve this problem, we cultured the cells (co-transformed with both the ORF 
plasmid and the λCI-CsgB plasmid) under non-inducing condition until they reached an 
optical density (OD) of about 0.8. We then added inducer to the cultures and let them 
grow for an additional 30 minutes or 1 hour. This time-frame allowed the cells to produce 
sufficient λCI-CsgB to be detectable on a Western blot before significant toxicity was 
observed. The results of the Western analysis, performed with samples harvested at both 
the 30-minute and the 1-hour time point, indicated that the λCI-CsgB fusion protein 
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levels in cell cultures overexpressing the experimental ORFs are similar to the levels seen 
in cell cultures overexpressing a control ORF (see Figure 3.4). These findings identify the 
MhpC, YdjO and YrhA proteins as worthwhile candidates to further characterize for their 
possible effects on CsgB amyloid formation in the E. coli cytoplasm.  
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Figure 3.4. The ORFs identified in the selection do not downregulate λCI -CsgB 
protein levels. (A) Western analysis of bacterial cultures expressing the indicated ORF 
and λCI-CsgB, grown for about 3 hours, induced with IPTG and grown for an additional 
30 minutes. The two lanes under each indicated ORF contain the same sample, the 
second lane containing a three-fold dilution of the sample in the first lane. The blot was 
probed with an anti-CI antibody. (B) Western blot of the same bacterial cultures as in (A) 
but grown for 1-hour post IPTG induction. The band above the λCI-CsgB protein band is 
an unspecific band always seen when the CI antibody is used and the bands below the 
full-length λCI-CsgB protein band represent degradation products. The signal seen at the 
top of the gel represents aggregated λCI-CsgB protein stuck on the well. 
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DISCUSSION 
 
In carrying out the work presented in this chapter, we set out to identify cellular 
factors that could affect prion formation in the bacterial cytoplasm. We used the 
conversion of a cytoplasmic version of the curli component, CsgB, to the amyloid 
conformation as a surrogate for initial prion formation. Taking advantage of the 
observation that the toxicity of the λCI -CsgB fusion protein correlates with the ability of 
the CsgB moiety to form amyloid-like aggregates, we designed a selection to identify 
factors that inhibit amyloid formation in E. coli.  Using the ASKA overexpression library 
[27], we identified three ORFs that when overexpressed, seem to inhibit λCI-CsgB 
amyloid dependent toxicity in E. coli. Importantly, these ORFs do not relieve the 
observed toxicity by merely reducing the levels of the λCI-CsgB fusion protein in the E. 
coli cells. However, the mechanisms by which these ORFs relieve λCI-CsgB mediated 
toxicity and potentially inhibit cytoplasmic amyloid formation remain to be investigated.  
 One of the identified ORFs encodes the conserved protein, YrhA, the function of 
which is not known.  One of the other ORFs encodes the predicted protein, YdjO. 
Although not much is known about the function of this protein in the cell, studies in E. 
coli have shown that ydjO transcription is downregulated when cells have to utilize 
alanine or acetate as their carbon source [28]. Under these conditions, bacteria generally 
increase the number of expressed genes that are involved in metabolism and motility. 
Interestingly, in a temporal study of gene expression in E. coli biofilms, Domka et al. 
reported ydjO upregulation in biofilms following 7 hours of culturing [29]. Together, 
these reports suggest a role for YdjO in biofilm formation as it is transcriptionally 
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upregulated in biofilm conditions [29], and conversely, downregulated under conditions 
that stimulate high motility [28]. 
The third identified ORF encodes the cytoplasmic hydrolase MhpC (2-hydroxy-6-
oxononatrienedioate hydrolase) involved in the catabolism of 3-(3-hydroxyphenyl) 
propionate, a carbon source used by bacteria in the absence of other preferred carbon 
sources [30]. A report has recently shown that mhpC is upregulated in E. coli cells 
deleted for rpoS, the gene encoding the σS subunit of the RNA polymerase, which 
controls the expression of genes involved in general stress resistance [31]. Interestingly, 
this same report indicated that RpoS contributes to biofilm maturation by regulating 
many genes involved in energy metabolism, motility and stress response. Cells deleted 
for rpoS cannot establish mature biofilms and it is in these cells that the group reports 
upregulation of the mhpC gene. Providing more support for the negative correlation 
between MhpC production and biofilm formation, the group reported mhpC 
downregulation in wild-type biofilms [31]. 
Although these reports do not suggest an explanation for how the identified ORFs 
might influence cytoplasmic amyloid formation, it is intriguing that they link YdjO and 
MhpC specifically to biofilm formation (though the correlations go in opposite 
directions). Furthermore, we cannot exclude the possibility that the ORF-encoded 
proteins influence, directly or indirectly, the ability of the λCI-CsgB fusion protein to 
associate with the DNA and thereby relieve fusion protein toxicity. 
A crucial question is whether these ORF-encoded proteins indeed lower the 
aggregating ability of the λCI -CsgB fusion protein. In principle, we could address this 
question by using the standard SDD-AGE method (described in CHAPTER 2) to 
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visualize SDS-stable fusion protein aggregates in cells co-expressing one of the selected 
ORFs or a control ORF. Unfortunately, however, the current system does not allow us to 
address the question in this way; whereas we can grow cells expressing the selected 
ORFs and the λCI -CsgB fusion protein and analyze their extracts for aggregates, we 
cannot do the same with the cells expressing a control ORF, as the aggregation of the 
λCI-CsgB fusion protein inhibits the growth of such cells. 
To test the effects of these ORFs on CsgB aggregation, we can instead take advantage 
of a previously characterized fusion protein consisting of the CsgB moiety at the N-
terminus of the global transcription activator CRP. In this context, conversion of CsgB to 
the amyloid fold does not result in cell toxicity (S. J. Garrity, unpublished data). Previous 
findings indicate that aggregation of the CsgB-CRP fusion protein leads to sequestration 
of the CRP protein and therefore result in a Crp- phenotype, which can be visualized as 
pale colonies on MacConkey maltose indicator plates (S. J. Garrity, unpublished data). 
(Note that CRP positively regulates genes required for the utilization of maltose as a 
carbon source.) Specifically, the CsgB-CRP fusion protein would be introduced alongside 
the mobilizable plasmid carrying one of the selected ORFs or a control ORF into a strain 
that has been deleted for the crp gene. If the ORF-encoded protein present on the 
mobilizable plasmid reduces the aggregating ability of the CsgB-CRP fusion protein, the 
increase in the amount of soluble CRP in the cell should result in a Crp+ phenotype and 
the cells should form red (or pink) colonies on MacConkey maltose indicator medium 
(Figure 3.5). In contrast, cells containing a control ORF will form pale colonies when 
grown under the same conditions. 
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Figure 3.5:  Experimental design to determine whether the selected ORFs 
decrease formation of CsgB amyloids. Aggregation of the CsgB-CRP fusion 
protein results in a Crp- phenotype, which is visualized as pale colonies on indicator 
medium. Overexpression of an ORF that inhibits amyloid formation, will result in a 
Crp+ phenotype, visualized as red colonies indicator plates.  
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Work in yeast has clearly demonstrated the critical importance of the cellular 
chaperone machinery in the formation and propagation of yeast prions, but aspects of 
these interactions remain unclear. Published work from this lab, as well as the work 
presented in CHAPTER 2, has established E. coli as a useful system for studying the 
behavior of yeast prions [18]. In addition, work from a former graduate student in the lab, 
Dr. Sean Garrity, has shown that altering chaperone levels influences the aggregation 
state of the Sup35 in E. coli. For instance, overproduction of ClpB, the Hsp104 homolog, 
not only seems to reduce the average size of the Sup35 polymers, but also seems to 
increase the infectivity of such aggregates.  In addition, overproduction of the DnaK 
system in E. coli, composed of DnaK (Hsp70), DnaJ (Hsp40) and GrpE (nucleotide 
exchange factor), alters the fluorescence pattern of the Sup35 protein from big twisted 
ribbons (correlated with amyloid structures) to primarily a diffuse pattern. The 
fluorescence pattern of New1, another yeast prion protein that can access the amyloid 
fold in bacteria (see CHAPTER 2), is also altered under these conditions from distinct 
foci (indicative of aggregation) to diffuse fluorescence. Although further studies are 
required to investigate the interaction of the DnaK system and prion amyloids in E. coli, 
these results suggest that alterations in the balance of bacterial chaperones can influence 
behavior of yeast prion proteins. 
Based on this preliminary work, it would be interesting to test the effects of the 
factors identified in this chapter (pending the results of experiments performed with the 
CsgB-CRP fusion protein) on the abilities of the New1 and NM proteins to access the 
prion conformation. In addition, one could also investigate the effects of the factors 
identified here on the propagation of the NM prion in the E. coli cytoplasm (see 
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CHAPTER 2). Collectively, these experiments will help identify the cellular players 
involved in amyloid formation and maintenance in the E. coli cytoplasm. 
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MATERIALS AND METHODS 
Plasmids, Strains and Cell growth 
Bacterial cultures were grown overnight and then diluted to OD600 0.02 in LB 
supplemented with the appropriate antibiotics (Carbenicillin 100 µg/ml; Chloramphenicol 
25 µg/ml) grown for about 3 hours at 370C and induced with the appropriate inducers 
IPTG at 125µM) for either 30minutes or 1hour.  
For the plate selection experiment, bacterial cultures cotransformed with the ASKA 
plasmid and the λCI -CsgB construct were plated on LB plates supplemented with the 
appropriate antiobiotic and IPTG. The plates were incubated overnight at 370C. 
The λCI -CsgB construct was produced from pACYC-derived plasmids under the 
control of the IPTG inducible promoter lacUV5.  
 
Bacterial Extract Preparation  
25ml cultures were grown to the indicated times and OD600 the was recorded. 
Bacterial cells were pelleted by centrifugation at 3000g for a period of 10 minutes. The 
bacterial pellets were then resuspended in 90% formic acid to solubilize the λCI -CsgB 
aggregates. The formic acid was removed by spinning the samples in a vacuum 
concentrator for about 10 minutes. The pellets were then resuspended in 1X SDS-PAGE 
loading dye and boiled for 15 minutes.  
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Western blot  
Blots were probed with anti-CI (gift from Dr. Jon Beckwith). Secondary antibodies 
were horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (Cell Signaling ab7074). 
Blots were detected using ECLplus Western Blotting Detection System (GE Healthcare). 
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SUMMARY 
The term prion was first coined by Prusiner in 1982 to describe the proteinaceous 
infectious particle causative of scrapie in sheep [1, 2]. Now it refers to self-propagating 
protein aggregates, which are usually comprised of highly structured beta-sheet-rich 
fibrils known as amyloids [3, 4]. The discovery of their existence in yeast has 
dramatically improved our understanding of prions, although many questions still remain 
unanswered. Yeast prions do not generally cause cell death and in fact act as heritable 
protein based genetic elements [5].  They confer new and stably inherited phenotypic 
states on the yeast cells harboring them.  
Studies in yeast have suggested a role for molecular chaperones in prion behavior. 
The most thoroughly characterized example is the Hsp104 chaperone, which plays a 
critical role in prion propagation. It is believed that Hsp104 cleaves large prion 
aggregates into smaller, more easily propagated species. However, it is still not clear 
whether Hsp104 works alone or with other chaperones in this function. It is also not 
known if the Hsp104 generated propagons are passaged to daughter cells in an active or 
passive process [6, 7]. Interestingly, no Hsp104 homolog has been found in humans, 
although one exists in plants. It should be noted that other chaperones have also been 
implicated in both the de novo biogenesis of prions and in their propagation, but their 
effects are complex and have been difficult to tease apart.  
Since the discovery of yeast prions many years ago, the number of known and 
putative yeast prions has grown enormously and continues to grow. However, it is not 
known if prions exist outside the eukaryotic domain of life. Bacteria produce 
extracellular non-prion amyloids, but it is not known if bacteria contain proteins that can 
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access a prion-like state. If such proteins exist, bacteria could utilize prion-like aggregates 
as epigenetic switches that could potentially help the cells adapt to a variety of stress 
conditions. 
As a first step in addressing the existence of bacterial prions, it is important to 
investigate the ability of the bacterial cytoplasm in supporting the de novo biogenesis and 
propagation of prions. Using a well-characterized Saccharomyces cerevisiae prion 
protein, Sup35, a study from this lab already established that infectious protein 
aggregates could indeed form in bacterial cells. The study also demonstrated that the 
formation of these aggregates was dependent on the presence of amyloid aggregates of 
another yeast prion protein, New1. The dependence of Sup35 aggregation on the presence 
of another aggregated prion protein is also observed in yeast, where it is known as the 
PIN effect. It is interesting that the PIN dependence of Sup35 aggregation in yeast was 
recapitulated in bacteria, although bacteria diverged from eukaryotes more than 2 billion 
years ago.  
In the work presented in this dissertation we examined whether the infectious Sup35 
aggregates formed in the bacterial cytoplasm in the presence of PIN could be propagated 
in bacteria. We found that, once formed, the Sup35 aggregates could be maintained in the 
bacterial cytoplasm for about 90 generations (CHAPTER 2). Propagation of these 
aggregates was not dependent on the presence of the transplanted PIN factor and this 
observation recapitulated the in vivo behavior of the Sup35 prion in yeast (namely, PIN is 
required for the de novo formation of the Sup35 prion, but not for its maintenance). Our 
experimental design tested for maintenance for up to about 90 generations and although 
we have no evidence to suggest that aggregate maintenance would not continue past this 
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point, additional experiments need to be carried out to answer the question of 
maintenance past 90 generations.  
We also sought to identify bacterial cellular factors that could affect amyloid 
aggregation in the bacterial cytoplasm (CHAPTER 3). We developed a selection capable 
of detecting factors that could interfere with amyloid formation in the E. coli 
environment. We used the aggregation of a well-studied bacterial protein, CsgB, as a 
surrogate for the initial conversion of a prion protein to the amyloid/prion conformation. 
In designing our selection, we also relied on the observation that, when fused to the 
bacteriophage lambda CI protein, CsgB causes cell toxicity that is dependent on the 
conversion of the fusion protein to the aggregated state. We used relief of toxicity as a 
readout in our selection to identify cellular factors that, when overproduced, could lower 
the aggregation propensity of the λCI-CsgB fusion protein. We were able to identify three 
open reading frames (ORFs) that, upon overexpression, potentially relieve the λCI-CsgB 
dependent toxicity.  Although the mechanisms by which the ORF-encoded proteins 
relieve λCI-CsgB mediated toxicity and potentially influence amyloid formation remain 
to be investigated, these proteins do not seem to relieve toxicity by merely 
downregulating fusion protein production or destabilizing the fusion protein.  
The work presented in this dissertation demonstrates that E. coli is an experimental 
system useful in studying the behavior of known and putative prion proteins. It 
established that the bacterial cytoplasm is capable of supporting not only formation of 
prion aggregates, but also their propagation. It also identified three bacterial proteins as 
candidate factors that may modify the behavior of amyloid forming proteins in the 
bacterial cytoplasm. Together, these findings help establish a framework for using 
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bacteria to study the complex interaction of chaperones and prions and they increase our 
interest in the search for bacterial proteins that exhibit prion-like behavior. 
 
FUTURE DIRECTIONS 
Experiments to better understand heritability of yeast prions in bacteria 
As previously mentioned, once formed, prions are stably inherited in the yeast cells 
harboring them. Although the work presented in this dissertation has shown that it is 
possible for yeast prions to be maintained in the bacterial cytoplasm, we have not yet 
been able to address the question of prion stability in bacteria. Two main issues with our 
current system hamper our ability to do so.  
First, our system for studying heritability of the Sup35NM (hereafter referred to as 
NM) prion depends on the ability to remove the PIN-encoding gene, new1, from the 
system once the prion aggregates have formed. At the present time, new1 is inserted in 
the bacteria chromosome at the lambda attachment site, and the excisionase machinery is 
provided on a plasmid under the control of a temperature sensitive promoter. This system 
results in low new1 removal efficiency (CHAPTER 2), limiting the number of colonies 
available to us for the subsequent analysis of NM aggregate maintenance. A way to 
increase the efficiency of new1 loss from the system would be to provide the new1 gene 
on a plasmid that contains a temperature sensitive origin of replication. In this system, 
transition of the bacterial cells to the non-permissive temperature following initial NM 
aggregation would allow for easy removal of the PIN factor. We could then study the 
heritability of NM prions in bacterial clones that have lost the PIN factor. 
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Second, for reasons we do not fully understand, the system we use for the production 
of the NM protein results in highly variable protein levels, not only from experiment to 
experiment, but also from colony to colony in the same experiment as well as over time 
in the same clone. This makes the study of heritability especially difficult because the 
propagation of NM aggregates necessarily depends on the continuing synthesis of the 
NM protein. Although a range of NM protein levels can result in NM aggregation, it is 
expected that aggregates will no longer form once NM levels drop below a certain 
(unknown) threshold.  
Upon initial consideration, it might seem possible to investigate the stability of the 
NM prion in our current system by simply looking for NM aggregates among bacterial 
clones with high levels of NM protein. The identification of clones that lack NM 
aggregates but contain NM levels similar to other NM aggregate-containing clones would 
suggest that NM aggregates are lost at a significantly higher frequency in bacteria than in 
the native yeast system. However, NM protein levels can vary during the course of 
growth of the bacterial culture (see CHAPTER 2). High protein levels at a certain point 
during growth provide no guarantee that those protein levels were consistently present in 
the bacterial culture. Since we cannot interpret the absence of NM aggregates even when 
we observe high NM protein levels at the time the cells are harvested, we cannot 
currently draw any conclusions concerning the stability of the NM prion aggregates in 
bacteria. 
In order to study stability of the NM prion in bacteria we need to modify the current 
system so that NM protein levels remain constant throughout the experiment. Based on 
our initial studies, the fluctuation in the NM levels seems to be tied to the arabinose 
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inducible system driving expression of the NM encoding gene in bacteria.  Specifically, 
we observe fluctuation in protein levels in the case of the NM protein, where expression 
of the gene is driven by an arabinose inducible promoter, but not in the case of the New1 
protein, where expression of the gene is under the control of an IPTG inducible promoter 
(see SUPPLEMENT TO CHAPTER 2). Based on this observation, we suggest providing 
NM under the control of an IPTG inducible promoter. We expect that this new induction 
system would provide the consistent levels of NM needed for the study of prion stability 
in bacteria.  This modification, combined with the new method of removing PIN from the 
system, would allow us to conduct a more quantitative analysis of prion stability in the 
bacterial cytoplasm. Current efforts in our lab are directed at implementing these changes 
in our experimental system.  
In this new system, we would initially grow the starter culture under inducing 
conditions for both NM and New1. Since production of both proteins would now be 
dependent on IPTG, it would no longer be possible induce the synthesis of NM 
independently of New1 in the starter culture serving as the negative control (culture B; 
see CHAPTER 2). Instead, culture B would contain the plasmid providing NM alongside 
the corresponding empty plasmid used to provide New1. This would ensure that both the 
NM and New1 proteins are produced upon induction with IPTG in culture A, but only the 
NM protein is produced in culture B. Following formation of the NM aggregates in 
culture A, the bacterial cells would be transitioned to the non-permissive temperature for 
the temperature-sensitive replicon of the New1 plasmid. This would result in loss of the 
New1 encoding plasmid from culture A, and loss of the corresponding empty plasmid 
from culture B. We would then analyze extracts from bacterial cultures grown from a 
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number (e.g., 10) of individual colonies confirmed to have lost the new1 gene; 
specifically we would assess NM protein levels by Western blot and test for the presence 
of aggregates by SDD-AGE. This same analysis would be carried out for both culture A 
and B derivatives. The fraction of NM aggregate-containing colonies among the number 
of culture A derived colonies analyzed in this round (Round 1 in Fig. 2.7 of CHAPTER 
2) would provide information on the stability of the NM aggregates in the bacterial 
cytoplasm. For example, the presence of NM aggregates in all the colonies analyzed, 
would suggest that NM aggregates are stably maintained in E. coli. However, the 
presence of NM aggregates in only a portion of the analyzed colonies, would suggest that 
NM aggregates are not as stable in bacteria as they are in yeast. Following analysis in 
Round 1, we would pick a fraction of the NM-aggregate containing colonies (e.g., 4) and 
restreak them for single colonies for Round 2 (Fig. 2.7 of CHAPTER 2). For each of the 
4 clones selected in Round 1, we would analyze extracts from overnight cultures grown 
from 10 individual colonies from Round 2 for NM protein levels and NM aggregates. 
This would allow us to calculate the frequency of NM-aggregate containing colonies in 
Round 2 for each of the 4 clones selected from Round 1. We would then proceed in the 
same way through the remaining rounds of Fig. 2.7, calculating the frequency of 
aggregate-containing colonies in each round for each of the 4 clones selected from Round 
1. The same analysis would be carried out with culture B derivative clones from Round 1. 
This experiment would allow us to quantitatively study the stability of NM aggregates 
through all of the 4 rounds of Fig. 2.7.  If the proportion of NM aggregate containing 
colonies does not change for each of the clones from round to round, we would conclude 
that the stability of the NM aggregates in the E. coli cytoplasm does not change upon 
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additional rounds of restreaking. If however, we observe a decrease in the proportion of 
NM-aggregate colonies as we move from round to round, we would conclude that NM 
aggregates cannot be maintained indefinitely in the bacterial cytoplasm and would 
eventually be lost following additional rounds of restreaking.  
In addition to expanding our understanding of yeast prion heritability in bacteria, the 
redesigned system outlined above would allow us to test the effect of both bacterial 
chaperones and transplanted yeast chaperones on the processes of prion formation and 
propagation. In fact, preliminary work carried out by Dr. Sean Garrity, a former graduate 
student in the lab, already suggest a role for ClpB, the bacterial Hsp104 homolog, in yeast 
prion behavior in bacteria. Specifically, he showed that overproduction of ClpB not only 
decreased the average size of the NM aggregates, but it also increased their infectivity (S. 
J. Garrity, unpublished data).  
Additionally, his preliminary experiments showed that overproduction of the E. coli 
DnaK/DnaJ chaperone system (the bacterial Hsp70/Hsp40 homolog) alters the 
fluorescence pattern of the NM-YFP fusion protein. When produced in the presence of 
the New1-CFP fusion protein, which serves as a PIN factor, the NM-YFP fusion protein 
forms twisted ribbon-like structures that transverse the length of the cell as analyzed by 
fluorescence microscopy [8]. In these same cells, the New1-CFP fusion protein forms a 
bright focus, from which the NM-YFP ribbons seem to emanate [8]. The presence of 
these NM-YFP ribbons correlates with SDS-stable NM aggregates as assayed by SDD-
AGE. It is important to note that neither NM-YFP ribbons nor NM-YFP stable aggregates 
are observed in cells missing the PIN factor [8]. Interestingly, when S. J. Garrity 
overproduced the DnaK system, consisting of DnaK (Hsp70), DnaJ (Hsp40), and GrpE (a 
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nucleotide exchange factor) in E. coli cells producing both NM-YFP and New1-CFP, he 
observed that the fluorescence pattern of the NM-YFP protein changed from twisted 
ribbons to a primarily diffuse pattern throughout the cell, suggesting that the E. coli 
DnaK/DnaJ system might interact with prion aggregates. Similarly, the fluorescence 
pattern of the New1-CFP protein changed from distinct foci to a primarily diffuse pattern 
(S. J. Garrity, unpublished data). 
Based on these observations, it would be interesting to test the effect of 
overproducing specific chaperones, bacterial or yeast, on the formation and infectivity of 
the NM prion, as well as on its stability in the bacterial cytoplasm. To test the effect of 
chaperone overproduction on the formation of NM aggregates, we would simply 
overproduce the specific chaperone in cells producing both NM-YFP and New1-CFP and 
analyze the bacterial extracts for NM-YFP protein levels and aggregates as compared to 
extracts from cells producing the same fusion proteins in the context of normal chaperone 
levels. The infectivity of the material generated under the two conditions (chaperone 
overproduction and normal chaperone levels) would then be tested by transforming yeast 
cells as previously described in CHAPTER 2. Additionally, we can test the effect of 
chaperone overproduction on other yeast proteins that form prion-like aggregates in the 
bacterial cytoplasm. The New1-CFP fusion protein would be a good candidate for this 
study as this protein has been shown to form SDS-stable aggregates in E. coli [8], though 
in this case there is no convenient assay for infectivity.  
Testing the effect of chaperone overproduction on prion maintenance, as opposed to 
prion formation, would require additional tools. In particular, in the case of NM, we 
would need to place the specific chaperone(s) being studied under the control of a tightly 
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regulated promoter, enabling us to overproduce the chaperone only after initial formation 
of the NM aggregates. For these experiments, the NM aggregates would be allowed to 
form in cells producing the PIN factor and normal levels of the chaperone being studied. 
Then, bacterial cells would then be transitioned to conditions allowing for the 
simultaneous removal of the PIN factor and the overproduction of the chaperone. This set 
up would ensure that we test the effect of overproducing the chaperone only on the 
propagation of the NM prion, not on its formation. The cells would then be carried 
though the steps outlined in Figure 2.7, CHAPTER 2 and the bacterial extracts would be 
studied for presence of NM aggregates as previously described. The infectivity of these 
aggregates would also be analyzed. Important for the interpretation of the results of these 
experiments would be the results from parallel experiments where the PIN factor is still 
removed, but the chaperone is not overproduced following NM aggregation.  
A promising area for immediate application of the system described here is the 
question of whether Hsp104 functions alone in prion propagation or whether it 
collaborates with the Hsp70/Hsp40 chaperone system the way it does in disaggregating 
and reactivating misfolded proteins after heat shock.  In vitro studies have shown that 
Hsp104 can function alone in fragmenting prion fibers, however other in vitro studies 
suggest that this activity is enhanced by Hsp70/Hsp40 factors [9-11]. Moreover, studies 
suggest a role for the Hsp70/Hsp40 factors in prion propagation in vivo [12-15]. 
However, it is unclear whether or not Hsp104 can function independently of the 
Hsp70/Hsp40 chaperone system to facilitate prion propagation in vivo. Because studies of 
Hsp104/ClpB-mediated thermotolerance have shown that these factors co-operate with 
their respective Hsp70/Hsp40 partners in a species-specific manner, our modified 
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bacterial system would allow us to test the effect of Hsp104 on NM prion propagation in 
a cellular setting that lacks the cognate Hsp70/Hsp40 partners. In particular, prior studies 
suggest that the bacterially produced Hsp104 will not collaborate with the bacterial 
Hsp70/Hsp40 (DnaK/DnaJ) system [15-18]. The proposed experiment would be carried 
out in a ΔclpB strain in order to clearly distinguish between effects of Hsp104 and effects 
of ClpB (and also to avoid complications due to the possible formation of mixed 
ClpB/Hsp104 oligomers). Thus, we would first need to test the effect of deleting clpB (or 
depleting ClpB) on NM prion behavior (see below) before being able to interpret an 
experiment designed to test the effect of Hsp104.  If we find that formation and/or 
propagation of the NM prion in the bacterial system depends on ClpB, then asking 
whether or not Hsp104 can substitute functionally for ClpB would be of particular 
interest.  
The chaperone overproduction studies proposed here would be nicely complemented 
by deletion studies. Of course, the deletion studies would only be carried out with 
bacterial chaperones. To study the effect of the deletion of certain chaperones on NM 
prion formation in the bacterial cytoplasm, we would carry out experiments similar to the 
overproduction experiments with the modification that the specific chaperone would be 
deleted, instead of overproduced, and the behavior of the yeast prion in the deletion 
strains would be compared to the behavior in the stain producing normal levels of the 
chaperone. It is important to note that in the case of essential proteins, such as Hsp70 
(DnaK), these deletion studies would have to be carried out in specific bacterial strains 
containing suppressor mutations. Studying the effect of chaperone deletion on NM prion 
maintenance would be straightforward only for chaperones that are not required for 
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formation of the NM prion.  For chaperones that are required for NM prion formation, a 
depletion strategy could be used to assess whether or not the same chaperone is required 
to maintain the prion, but the experimental design would be challenging given the need to 
remove the PIN factor and simultaneously remove or deplete the chaperone.  
Finally, our modified bacterial system could be used to study the heritability of other 
known yeast prions as well as study their interaction with the chaperone systems.  The 
approach to studying the heritability of yeast prions that depend on PIN for initial 
conversion to the prion fold would be similar to the modified approach we plan to use to 
study the heritability of the NM prion. On the other hand, in order to study the heritability 
of yeast prions that do not depend on a PIN factor for their initial formation, we would 
need to be able to identify protein levels that suffice for prion maintenance but not for 
initial formation. This would require a vector that provides for a well controlled range of 
protein concentrations as a function of inducer concentration. To carry out the 
experiment, we would allow the prion to form by culturing the cells at an induction level 
experimentally shown to allow for initial aggregate formation. We would then transition 
the cells to lower induction levels shown to be insufficient for de novo aggregate 
formation. This set-up would allow us to study the propagation of these prions in E. coli. 
Additionally, we could test the effect of chaperones on their behavior in the same manner 
suggested for the NM prion.  
 
Further characterization of the three ORFs implicated in relieving the toxicity of the 
CI-CsgB fusion protein  
In the work presented in this thesis, we identified three bacterial open reading frames 
(ORFs) that potentially inhibit cytoplasmic amyloid aggregation. However, with our 
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current set-up, we are unable to test their effect on the formation of SDS-stable 
aggregates due to the fact that the CI-CsgB fusion protein is toxic (except under 
conditions where one of the identified ORFs is being overexpressed). To circumvent this 
problem, the effect of the overexpression of the ORF on amyloid aggregation can be 
tested under conditions where the CsgB aggregation in the bacterial cytoplasm does not 
correlate with cell toxicity.  
Previous studies in the lab have shown that when CsgB is fused to the global 
transcription activator CRP, the resulting fusion protein can still access the amyloid 
conformation. Importantly, in this context, fusion protein aggregation does not cause cell 
toxicity.  Additionally, Δcrp cells containing the CsgB-CRP fusion protein exhibit a Crp- 
phenotype (visualized as pale colonies on MacConkey maltose indicator plates), 
presumably because the CRP moiety is sequestered in fusion protein aggregates and 
unable to activate transcription. In fact, the aggregation deficient version of the CsgB 
protein, CsgB Q117R, described in CHAPTER 3, was identified by introducing random 
mutations into the csgB moiety of the csgB-crp fusion gene, transforming the 
mutagenized library into a Δcrp reporter strain, and screening for red colonies on 
MacConkey maltose indicator plates (S. J. Garrity, unpublished data). 
The use of the CsgB-CRP fusion protein will allow us to test directly whether or not 
overexpression of the identified ORFs influences the aggregation propensity of the CsgB 
moiety. A Δcrp reporter strain would be co-transformed with the CsgB-CRP encoding 
plasmid and one of the identified ORFs (or a control ORF).  Transformants would then be 
cultured under inducing conditions for both the CsgB-CRP and ORF constructs, and cell 
extracts would be analyzed for SDS-stable fusion protein aggregates by SDD-AGE. In 
	   119	  
parallel, we would analyze the cell extracts for fusion protein levels by Western blot to 
ensure that the experimental samples and the control sample contain similar amounts of 
fusion protein. If the ORF present reduces the aggregating ability of the CsgB-CRP 
fusion protein, it would result in a weaker or absent SDD-AGE smear as compared to the 
sample containing the control ORF. Additionally, such an ORF would result in red or 
pinker colonies (when grown on MacConkey indicator medium supplemented with 
inducers for both constructs) as compared to the pale colonies formed by cells containing 
CsgB-CRP and a control ORF, providing us with another method to investigate the 
aggregation state of the CsgB-CRP fusion protein.   
The overexpression experiments would be complemented nicely by deletion 
experiments, where we would test the effect of deleting the ORFs on the aggregating 
propensity of the CsgB-CRP fusion protein. If ORF overexpression inhibits the 
aggregation of the CsgB-CRP fusion protein, we would expect their deletion to either 
have no effect on the aggregation of the fusion protein or result in an increased 
aggregation of the CsgB-CRP fusion protein as compared to conditions of control ORF 
overexpression. For these studies, we would initially test the effect of deleting each of the 
three ORFs, one at a time, on the aggregating propensity of CsgB-CRP. These 
experiments would be carried out similarly to the overexpression experiments, except that 
we would compare the levels of aggregated CsgB-CRP fusion protein in cells lacking one 
of the ORFs to those in the wild-type strain. Although very unlikely, it is possible to 
imagine that all of the identified ORFs could inhibit CsgB aggregation by the same 
mechanism, and could therefore compensate for each other’s absence. In that scenario, 
deleting only one of the ORFs would not have any effect on the behavior of the CsgB-
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CRP fusion protein and deleting all of the ORFs at the same time would be required to 
study their effect on the aggregation of the CsgB-CRP fusion protein.  
 If the above experiments demonstrate that the ORFs reduce the aggregation 
propensity of the CsgB-CRP fusion protein, it would be interesting to investigate whether 
they also inhibit conversion to the amyloid fold for other amyloid forming proteins, in 
addition to CsgB-CRP. As a first step in addressing this question, we can easily test the 
effect of their overexpression on the formation of NM and New1 aggregates in the 
bacterial cytoplasm. If overexpression of any of these ORFs interferes with a critical step 
in amyloid formation, we would expect to see decreased amounts of aggregated NM and 
New1 (as assessed by SDS-AGE) when these aggregates are allowed to form in cells 
overexpressing that ORF. These experiments would be carried out similarly to 
experiments designed to test the effect of chaperone overproduction on aggregate 
formation.  
Finally, the newly designed system for the study of prion heritability in E. coli could 
be used to investigate a possible effect of the overexpression of these ORFs on prion 
heritability. The set-up for these experiments would be very similar to the one described 
to test the effect of chaperone overproduction on NM prion stability. Combined with the 
other experiments described here, these studies would help us better understand the 
interaction of bacterial cellular factors with yeast prions and amyloidogenic proteins.  
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